<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Cardiovasc Diabetol</journal-id><journal-title>Cardiovascular Diabetology</journal-title><issn pub-type="epub">1475-2840</issn><publisher><publisher-name>BioMed Central</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">19604407</article-id><article-id pub-id-type="pmc">2724493</article-id><article-id pub-id-type="publisher-id">1475-2840-8-35</article-id><article-id pub-id-type="doi">10.1186/1475-2840-8-35</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Investigation</subject></subj-group></article-categories><title-group><article-title>Beneficial effects of a Paleolithic diet on cardiovascular risk factors in type 2 diabetes: a randomized cross-over pilot study</article-title></title-group><contrib-group><contrib id="A1" corresp="yes" contrib-type="author"><name><surname>J&#x000f6;nsson</surname><given-names>Tommy</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>Tommy.Jonsson@med.lu.se</email></contrib><contrib id="A2" contrib-type="author"><name><surname>Granfeldt</surname><given-names>Yvonne</given-names></name><xref ref-type="aff" rid="I2">2</xref><email>Yvonne.Granfeldt@food.lth.se</email></contrib><contrib id="A3" contrib-type="author"><name><surname>Ahr&#x000e9;n</surname><given-names>Bo</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>Bo.Ahren@med.lu.se</email></contrib><contrib id="A4" contrib-type="author"><name><surname>Branell</surname><given-names>Ulla-Carin</given-names></name><xref ref-type="aff" rid="I3">3</xref><email>Ulla-Carin.branell@skane.se</email></contrib><contrib id="A5" contrib-type="author"><name><surname>P&#x000e5;lsson</surname><given-names>Gunvor</given-names></name><xref ref-type="aff" rid="I2">2</xref><email>Gunvor.A.Palsson@skane.se</email></contrib><contrib id="A6" contrib-type="author"><name><surname>Hansson</surname><given-names>Anita</given-names></name><xref ref-type="aff" rid="I2">2</xref><email>anitadalby@telia.com</email></contrib><contrib id="A7" contrib-type="author"><name><surname>S&#x000f6;derstr&#x000f6;m</surname><given-names>Margareta</given-names></name><xref ref-type="aff" rid="I4">4</xref><email>M.Soderstrom@pubhealth.ku.dk</email></contrib><contrib id="A8" contrib-type="author"><name><surname>Lindeberg</surname><given-names>Staffan</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>Staffan.Lindeberg@med.lu.se</email></contrib></contrib-group><aff id="I1"><label>1</label>Department of Clinical Sciences, Lund, Lund University, Box 117, 221 00 Lund, Sweden</aff><aff id="I2"><label>2</label>Department of Food Technology, Engineering and Nutrition, Lund University, Lund, Sweden</aff><aff id="I3"><label>3</label>Primary Health Care, Region Sk&#x000e5;ne, Regionhuset, Barav&#x000e4;gen, 221 00 Lund, Sweden</aff><aff id="I4"><label>4</label>Department of Clinical Sciences, Malm&#x000f6;, CRC, 205 02 Malm&#x000f6;, Sweden</aff><pub-date pub-type="collection"><year>2009</year></pub-date><pub-date pub-type="epub"><day>16</day><month>7</month><year>2009</year></pub-date><volume>8</volume><fpage>35</fpage><lpage>35</lpage><ext-link ext-link-type="uri" xlink:href="http://www.cardiab.com/content/8/1/35"/><history><date date-type="received"><day>23</day><month>6</month><year>2009</year></date><date date-type="accepted"><day>16</day><month>7</month><year>2009</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2009 J&#x000f6;nsson et al; licensee BioMed Central Ltd.</copyright-statement><copyright-year>2009</copyright-year><copyright-holder>J&#x000f6;nsson et al; licensee BioMed Central Ltd.</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0"><p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/2.0"/>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</p><!--<rdf xmlns="http://web.resource.org/cc/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dc="http://purl.org/dc/elements/1.1" xmlns:dcterms="http://purl.org/dc/terms"><Work xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" rdf:about=""><license rdf:resource="http://creativecommons.org/licenses/by/2.0"/><dc:type rdf:resource="http://purl.org/dc/dcmitype/Text"/><dc:author>
               J&#x000f6;nsson
               Tommy
               
               Tommy.Jonsson@med.lu.se
            </dc:author><dc:title>
            Beneficial effects of a Paleolithic diet on cardiovascular risk factors in type 2 diabetes: a randomized cross-over pilot study
         </dc:title><dc:date>2009</dc:date><dcterms:bibliographicCitation>Cardiovascular Diabetology 8(1): 35-. (2009)</dcterms:bibliographicCitation><dc:identifier type="sici">1475-2840(2009)8:1&#x0003c;35&#x0003e;</dc:identifier><dcterms:isPartOf>urn:ISSN:1475-2840</dcterms:isPartOf><License rdf:about="http://creativecommons.org/licenses/by/2.0"><permits rdf:resource="http://web.resource.org/cc/Reproduction" xmlns=""/><permits rdf:resource="http://web.resource.org/cc/Distribution" xmlns=""/><requires rdf:resource="http://web.resource.org/cc/Notice" xmlns=""/><requires rdf:resource="http://web.resource.org/cc/Attribution" xmlns=""/><permits rdf:resource="http://web.resource.org/cc/DerivativeWorks" xmlns=""/></License></Work></rdf>--></license></permissions><abstract><sec><title>Background</title><p>Our aim was to compare the effects of a Paleolithic ('Old Stone Age') diet and a diabetes diet as generally recommended on risk factors for cardiovascular disease in patients with type 2 diabetes not treated with insulin.</p></sec><sec sec-type="methods"><title>Methods</title><p>In a randomized cross-over study, 13 patients with type 2 diabetes, 3 women and 10 men, were instructed to eat a Paleolithic diet based on lean meat, fish, fruits, vegetables, root vegetables, eggs and nuts; and a Diabetes diet designed in accordance with dietary guidelines during two consecutive 3-month periods. Outcome variables included changes in weight, waist circumference, serum lipids, C-reactive protein, blood pressure, glycated haemoglobin (HbA1c), and areas under the curve for plasma glucose and plasma insulin in the 75 g oral glucose tolerance test. Dietary intake was evaluated by use of 4-day weighed food records.</p></sec><sec><title>Results</title><p>Study participants had on average a diabetes duration of 9 years, a mean HbA1c of 6,6% units by Mono-S standard and were usually treated with metformin alone (3 subjects) or metformin in combination with a sulfonylurea (3 subjects) or a thiazolidinedione (3 subjects). Mean average dose of metformin was 1031 mg per day. Compared to the diabetes diet, the Paleolithic diet resulted in lower mean values of HbA1c (-0.4% units, <italic>p </italic>= 0.01), triacylglycerol (-0.4 mmol/L, <italic>p </italic>= 0.003), diastolic blood pressure (-4 mmHg, <italic>p </italic>= 0.03), weight (-3 kg, <italic>p </italic>= 0.01), BMI (-1 kg/m<sup>2</sup>, <italic>p </italic>= 0.04) and waist circumference (-4 cm, <italic>p </italic>= 0.02), and higher mean values of high density lipoprotein cholesterol (+0.08 mmol/L, <italic>p </italic>= 0.03). The Paleolithic diet was mainly lower in cereals and dairy products, and higher in fruits, vegetables, meat and eggs, as compared with the Diabetes diet. Further, the Paleolithic diet was lower in total energy, energy density, carbohydrate, dietary glycemic load, saturated fatty acids and calcium, and higher in unsaturated fatty acids, dietary cholesterol and several vitamins. Dietary GI was slightly lower in the Paleolithic diet (GI = 50) than in the Diabetic diet (GI = 55).</p></sec><sec><title>Conclusion</title><p>Over a 3-month study period, a Paleolithic diet improved glycemic control and several cardiovascular risk factors compared to a Diabetes diet in patients with type 2 diabetes.</p></sec><sec><title>Trial registration</title><p>ClinicalTrials.gov NCT00435240.</p></sec></abstract></article-meta></front><body><sec><title>Background</title><p>While dietary management is a cornerstone in the treatment of type 2 diabetes, high quality data on the efficacy of dietary treatment of type 2 diabetes are lacking, according to a recent Cochrane review [<xref ref-type="bibr" rid="B1">1</xref>]. Since nutritional science is hampered by confounders, an evolutionary approach has been suggested. It has been postulated that foods that were regularly eaten during human evolution, in particular during the Paleolithic (the 'Old Stone Age', 2.5&#x02013;0.01 million years BP), may be optimal for prevention and treatment of type 2 diabetes, CVD and insulin resistance [<xref ref-type="bibr" rid="B2">2</xref>,<xref ref-type="bibr" rid="B3">3</xref>]. A Paleolithic diet is a modern dietary regimen based on foods presumably eaten regularly during the Paleolithic, which includes lean meat, fish, shellfish, fruits, vegetables, roots, eggs and nuts, but not grains, dairy products, salt or refined fats and sugar, which became staple foods long after the appearance of fully modern humans.</p><p>To date, only a few studies have examined the effects of a Paleolithic diet on disease and risk factors for disease. In a randomized controlled study in 29 men with ischemic heart disease (IHD) and impaired glucose tolerance or type 2 diabetes (mean HbA1C 4.8% at baseline), we found improved glucose tolerance independent of weight-loss after 12 weeks of Paleolithic diet compared to a Mediterranean-like diet [<xref ref-type="bibr" rid="B4">4</xref>]. In the same study, the Paleolithic diet was reportedly lower in glycemic load (GL) than the Mediterranean-like diet [<xref ref-type="bibr" rid="B4">4</xref>]. The clinical relevance of glycemic index (GI) and GL is presently being discussed [<xref ref-type="bibr" rid="B5">5</xref>]. Some studies show beneficial effects of a low GI/GL diet on risk factors for CVD in diabetes, while other studies do not [<xref ref-type="bibr" rid="B6">6</xref>-<xref ref-type="bibr" rid="B8">8</xref>]. In a non-controlled study on 14 healthy individuals, &#x000d6;sterdahl et al found that three weeks on a Paleolithic diet significantly reduced weight, BMI, waist circumference, systolic blood pressure (SBP) and plasminogen activator inhibitor-1 (PAI-1) [<xref ref-type="bibr" rid="B9">9</xref>]. In another non-controlled study in nine healthy overweight individuals where intervention food was supplied and weight kept steady, Frassetto et al found that ten days of a Paleolithic diet improved diastolic blood pressure (DBP), glucose tolerance, insulin sensitivity and lipid profiles [<xref ref-type="bibr" rid="B10">10</xref>]. In a randomized controlled feeding trial in domestic swine, we found higher insulin sensitivity, lower C-reactive protein (CRP) and lower DBP after 15 months of a Paleolithic diet, compared with a cereal-based swine feed [<xref ref-type="bibr" rid="B11">11</xref>]. This study also showed a low-grade inflammation of the pancreas in the swine who had eaten a cereal based swine feed [<xref ref-type="bibr" rid="B11">11</xref>]. In a non-controlled study of ten Australian Aborigines with diabetes and a mean BMI of 27 kg/m<sup>2</sup>, O'Dea found that reversion to a hunter-gatherer lifestyle during 7 weeks led to 10% weight loss and reductions in fasting and 2 hour glucose and fasting insulin [<xref ref-type="bibr" rid="B12">12</xref>]. In a similar study on healthy Australian Aborigines by the same authors, the insulin response to 70 g of starch from white bread was reduced, while the glucose response was not, after 10&#x02013;12 weeks of reversion to a traditional lifestyle [<xref ref-type="bibr" rid="B13">13</xref>]. In an epidemiologic study, we found that traditional Pacific Islanders of Kitava, Papua New Guinea, had no signs of IHD, stroke or markers of the metabolic syndrome, possibly because of their traditional lifestyle [<xref ref-type="bibr" rid="B14">14</xref>-<xref ref-type="bibr" rid="B16">16</xref>]. Thus, we have previously shown beneficial effects from Paleolithic diet on glycemic control and risk markers for CVD in patients with IHD and in domestic pigs. No study, however, has so far examined the same potential beneficial effect of Paleolithic diet when compared to diabetes diet in subjects with type 2 diabetes.</p><p>In the present study, therefore, our aim was to examine the effect on glycemic control and risk factors for CVD of food-based (as opposed to macronutrient based) dietary advice according to this Paleolithic diet model over a 3-month period in patients with type 2 diabetes. The patients were recruited in a primary health care setting, and effects of a Paleolithic diet was compared with effects of dietary advice in accordance with current guidelines for people with diabetes [<xref ref-type="bibr" rid="B17">17</xref>].</p></sec><sec sec-type="methods"><title>Methods</title><sec><title>Patients</title><p>Approval of the study was obtained from the regional Medical Ethics Committee and the trial was registered at ClinicalTrials.gov (Identifier: NCT00435240). The study was a randomized, cross-over, dietary intervention study in 13 patients with type 2 diabetes without insulin treatment, 3 women and 10 men, recruited from three primary health care units in the Lund area in Sweden. We included adult patients with type 2 diabetes and a C-peptide value above zero, unaltered medical diabetes treatment and stable weight since three months before start of study, HbA1c above 5.5% by Mono-S standard, creatinine below130 &#x003bc;mol/L, liver enzymes below four times their respective upper reference value, no chronic oral or injection steroid treatment and no acute coronary event or change in medication of beta blockers or thyroxin since six months before start of study. Exclusion criteria during ongoing study were change in beta blocker or thyroxin medication, chronic oral or injection steroid treatment, warfarin treatment, creatinine above 130 &#x003bc;mol/L or liver enzymes above four times their respective upper reference value, acute coronary event, and physical or psychological illness or changes in personal circumstances which would make further study participation impossible.</p><p>Recruitment for the study during routine clinical work was performed by TJ, UCB, GP, AH and MS. In addition, a letter containing written study information was sent by TJ to subjects at two of the health stations who from journal data seemed to match the inclusion criteria. All recruited subjects were given oral and written study information prior to signing a consent form to participate in the study and were then further assessed for eligibility.</p></sec><sec><title>Procedure</title><p>All eligible subjects were informed of the intention to compare two healthy diets in the treatment of type 2 diabetes and that it was unknown if any of them would be superior to the other. At study start all eligible subjects were randomized to start with either a Diabetes diet in accordance with current guidelines [<xref ref-type="bibr" rid="B17">17</xref>] or a Paleolithic diet. Randomization was performed by UCB, GP and AH by opening opaque, sealed envelopes (prepared by TJ) containing a note of the initial diet with equal proportions of envelopes for both diets. After randomization, there was no blinding of dietary assignment to study participants, nor to those administering the interventions or assessing the outcomes. Immediately after randomization, all subjects received oral and written information individually (by UCB, GP or AH) in the morning about their respective initial diet. After three months all subjects switched diets and received new oral and written information individually (by UCB, GP or AH) about the diet of the following three months. Written information with dietary advice and food recipes were similarly formulated for both diets. For increased conformity, the dietary advice and data collection procedure were discussed by all authors except YG at several meetings prior to start of study. Advice about regular physical activity was given equally to all subjects.</p><p>The information on the Diabetes diet stated that it should aim at evenly distributed meals with increased intake of vegetables, root vegetables, dietary fiber, whole-grain bread and other whole-grain cereal products, fruits and berries, and decreased intake of total fat with more unsaturated fat. The majority of dietary energy should come from carbohydrates from foods naturally rich in carbohydrate and dietary fiber. The concepts of glycemic index and varied meals through meal planning by the Plate Model were explained [<xref ref-type="bibr" rid="B18">18</xref>]. Salt intake was recommended to be kept below 6 g per day.</p><p>The information on the Paleolithic diet stated that it should be based on lean meat, fish, fruit, leafy and cruciferous vegetables, root vegetables, eggs and nuts, while excluding dairy products, cereal grains, beans, refined fats, sugar, candy, soft drinks, beer and extra addition of salt. The following items were recommended in limited amounts for the Paleolithic diet: eggs (&#x02264;2 per day), nuts (preferentially walnuts), dried fruit, potatoes (&#x02264;1 medium-sized per day), rapeseed or olive oil (&#x02264;1 tablespoon per day), wine (&#x02264;1 glass per day). The intake of other foods was not restricted and no advice was given with regard to proportions of food categories (e.g. animal versus plant foods). The evolutionary rationale for a Paleolithic diet and potential benefits were explained [<xref ref-type="bibr" rid="B19">19</xref>].</p></sec><sec><title>Evaluation</title><p>An oral glucose tolerance test (OGTT) was performed in the morning after obtaining venous blood samples and measurements of blood pressure, weight and waist circumference in the primary care unit (by UCB, GP or AH) at study start, after 3 months (when switching to a new diet) and at the end of the study (after 6 months). 75 g glucose was ingested. Blood samples for plasma glucose and insulin during OGTT were obtained at 0, 15, 30, 60, 90 and 120 minutes. Changes in the area under the curve (AUC) between 0 and 120 min during OGTT for plasma glucose (AUC Glucose<sub>0&#x02013;120</sub>) and plasma insulin (AUC Insulin<sub>0&#x02013;120</sub>) were predefined primary endpoints, along with changes in body weight, waist circumference, serum lipids, CRP, blood pressure and glycated haemoglobin A1c (HbA1c) by Mono-S standard. The base of the AUC was set at 0 mmol/L for glucose and 0 pmol/L for insulin. The stimulated secretion was represented by the areas under the glucose and insulin curves using levels at 0 min as the base of the area. The Homeostatic model assessment (HOMA) was used for assessing beta-cell function (%B) and insulin sensitivity (%S), as percentages of a normal reference population, and insulin resistance (IR, the reciprocal of %S (100/%S)) [<xref ref-type="bibr" rid="B20">20</xref>]. Values for %B, %S, and IR were derived from fasting plasma glucose and insulin using the HOMA2 computer model v2.2 [<xref ref-type="bibr" rid="B20">20</xref>]. Insulin sensitivity index (ISI<sub>0,120</sub>) was calculated from fasting (0 min) and 120 min (post-OGTT) insulin and glucose concentrations [<xref ref-type="bibr" rid="B21">21</xref>]. A 4-day weighed food record on four consecutive days, including one weekend day, with weighing of each food item on a digital weighing scale (that could be set to zero), was completed by the participants, starting 6 weeks after initiating each diet. Nutrient compositions were calculated by YG using data from The Swedish Food Database of the National Food Administration in Sweden. GL and GI for the two diets were calculated. Underlying concept of dietary GL and dietary GI is food GI, introduced by Jenkins et al [<xref ref-type="bibr" rid="B22">22</xref>], reflecting the postprandial glucose response after a specific food rich in carbohydrate, expressing the quality of the carbohydrates. Wolever and Jenkins also suggested the possibility of ranking diets based on dietary GI calculated from the proportional GI contribution of the included foods containing carbohydrate [<xref ref-type="bibr" rid="B23">23</xref>]. To include also the quantity of carbohydrates consumed GL was introduced by Salmer&#x000f3;n et al expressing the glycemic effect of the diet [<xref ref-type="bibr" rid="B24">24</xref>]. While dietary GI is expressing the quality of the carbohydrates consumed GL represent both the quantity and the quality of the carbohydrates consumed. Thus, dietary GL in this study was calculated as the result from multiplying available carbohydrate (g) for the food reported by the subjects during the 4-day weighed food record with the specific food's GI divided by 100. Available carbohydrate was based on total carbohydrate minus dietary fibre. Food's GI values (glucose as reference) were taken from the compilation by Foster-Powel et al [<xref ref-type="bibr" rid="B25">25</xref>]. Dietary GI was calculated as 100 multiplied with dietary GL divided by the amount of available carbohydrate (g) in the diet.</p></sec><sec><title>Statistics</title><p>A pre-study power calculation showed that 15 subjects would be required to detect, with 80% power and at a significance level of 5%, a 15% reduction in AUC Glucose<sub>0&#x02013;120</sub>. Two-way paired t-test was used to analyze within-subject changes in absolute values, while two-way unpaired t-test was used to analyze between-subject changes in absolute values. All outcome variables showed reasonable normal distribution in normal plots. Within-subject changes in outcome variables after first and second diet and within-subject changes in reported dietary intake during first and second diet were used to check for period effects [<xref ref-type="bibr" rid="B26">26</xref>]. Mean values of outcome variables and reported dietary intakes for the group starting with Paleolithic diet was compared with the group starting with Diabetes diet in order to check for carry-over effects [<xref ref-type="bibr" rid="B26">26</xref>]. Exploratory analyses were performed on outcome variables with significant effects from the Paleolithic diet as compared to the Diabetes diet. Exploratory analyses consisted of bivariate correlations between within-subject differences (&#x00394;) in outcome and dietary variables. Significantly correlating variables were entered into a stepwise forward linear regression analyses.</p></sec></sec><sec><title>Results</title><sec><title>Recruitment and participant flow</title><p>The study started in January 2005 and the last participant was followed up in September 2007 after which the study was stopped. Out of 26 subjects assessed for eligibility, nine were not eligible since they did not meet the inclusion criteria or refused to participate. Out of the remaining 17 eligible subjects, who were all randomized and started on the study, four subjects were excluded for the following reasons: one starting with Paleolithic diet was wrongly included with ongoing warfarin treatment, one starting with Paleolithic diet was unwilling to continue due to abdominal pains and bloating, one starting with Diabetes diet was excluded after developing leukemia, and one starting with Diabetes diet was excluded after developing heart failure. All reported analyses are "per protocol" analyses on the 13 participants who completed the trial.</p></sec><sec><title>Medication</title><p>Study participants were on average treated with just above four drugs per day, which usually included metformin alone (3 subjects) or metformin in combination with a sulfonylurea (3 subjects) or a thiazolidinedione (3 subjects)(Table <xref ref-type="table" rid="T1">1</xref>, <xref ref-type="table" rid="T2">2</xref>). Medication usually also included a lipid lowering drug (8 of 13 study participants and always statin treatment) and more than one anti-hypertensive drug per day (Table <xref ref-type="table" rid="T1">1</xref>, <xref ref-type="table" rid="T2">2</xref>). All medication remained unchanged during the whole study with the following exceptions:</p><table-wrap position="float" id="T1"><label>Table 1</label><caption><p>Baseline characteristics (mean &#x000b1; SD)</p></caption><table frame="hsides" rules="groups"><tbody><tr><td align="left">Sex male/female (n)</td><td align="center">10/3</td></tr><tr><td align="left">Age (year)</td><td align="center">64 &#x000b1; 6</td></tr><tr><td align="left">Diabetes duration (year)</td><td align="center">8 &#x000b1; 5</td></tr><tr><td align="left">Diabetic values at OGTT yes/no (n)</td><td align="center">12/1</td></tr><tr><td align="left">Lipid lowering drug (= statin) yes/no (n)</td><td align="center">8/5</td></tr><tr><td align="left">Drugs per day</td><td align="center">4.3 &#x000b1; 2.3</td></tr><tr><td align="left">Anti-hypertensive drugs per day</td><td align="center">1.5 &#x000b1; 1.5</td></tr><tr><td align="left">&#x02003;Beta-blocker yes/no (n)</td><td align="center">4/9</td></tr><tr><td align="left">&#x02003;Thiazide yes/no (n)</td><td align="center">4/9</td></tr><tr><td align="left">&#x02003;ACE-inhibitor yes/no (n)</td><td align="center">5/8</td></tr><tr><td align="left">&#x02003;Angiotensin-II receptor blocker yes/no (n)</td><td align="center">4/9</td></tr><tr><td align="left">&#x02003;Calcium channel blocker yes/no (n)</td><td align="center">3/10</td></tr><tr><td align="left">Anti-diabetic drugs per day</td><td align="center">1.2 &#x000b1; 0.9</td></tr><tr><td align="left">&#x02003;Metformin yes/no (n)</td><td align="center">9/4</td></tr><tr><td align="left">&#x02003;Sulfonylurea yes/no (n)</td><td align="center">3/10</td></tr><tr><td align="left">&#x02003;Thiazolidinedione yes/no (n)</td><td align="center">3/10</td></tr><tr><td align="left">Metformin per day (mg)</td><td align="center">1031 &#x000b1; 864</td></tr><tr><td align="left">HbA1C (%, Mono-S)</td><td align="center">6.6 &#x000b1; 0.6</td></tr><tr><td align="left">Cholesterol (mmol/l)</td><td align="center">4.4 &#x000b1; 1.1</td></tr><tr><td align="left">LDL (mmol/l)</td><td align="center">2.9 &#x000b1; 0.9</td></tr><tr><td align="left">HDL (mmol/l)</td><td align="center">1.28 &#x000b1; 0.22</td></tr><tr><td align="left">TG (mmol/l)</td><td align="center">1.5 &#x000b1; 0.7</td></tr><tr><td align="left">CRP (mg/l)</td><td align="center">2.4 &#x000b1; 1.8</td></tr><tr><td align="left">SBP (mmHg)</td><td align="center">150 &#x000b1; 21</td></tr><tr><td align="left">DBP (mmHg)</td><td align="center">83 &#x000b1; 10</td></tr><tr><td align="left">Height (cm)</td><td align="center">171 &#x000b1; 5</td></tr><tr><td align="left">Weight (kg)</td><td align="center">87 &#x000b1; 17</td></tr><tr><td align="left">BMI (kg/m<sup>2</sup>)</td><td align="center">30 &#x000b1; 7</td></tr><tr><td align="left">Waist (cm)</td><td align="center">103 &#x000b1; 14</td></tr><tr><td align="left">fP-glucose (mmol/l)</td><td align="center">7.8 &#x000b1; 1.2</td></tr><tr><td align="left">fP-insulin (pmol/l)</td><td align="center">98 &#x000b1; 44</td></tr><tr><td align="left">AUC glucose<sub>0&#x02013;120 </sub>(mmol/l&#x000b7;min)</td><td align="center">1607 &#x000b1; 218</td></tr><tr><td align="left">AUC glucose<sub>0&#x02013;120 </sub>(mmol/l&#x000b7;min)<sup>1</sup></td><td align="center">667 &#x000b1; 186</td></tr><tr><td align="left">AUC insulin<sub>0&#x02013;120 </sub>(nmol/l&#x000b7;min)</td><td align="center">30 &#x000b1; 12</td></tr><tr><td align="left">AUC insulin<sub>0&#x02013;120 </sub>(nmol/l&#x000b7;min)<sup>1</sup></td><td align="center">18 &#x000b1; 8</td></tr><tr><td align="left">ISI<sub>0,120 </sub>(mg&#x000b7;l<sup>2</sup>/mmol&#x000b7;mU&#x000b7;min)</td><td align="center">40 &#x000b1; 9</td></tr><tr><td align="left">HOMA2 %B</td><td align="center">65 &#x000b1; 34</td></tr><tr><td align="left">HOMA2 %S</td><td align="center">59 &#x000b1; 27</td></tr><tr><td align="left">HOMA2 IR</td><td align="center">2.0 &#x000b1; 0.8</td></tr></tbody></table><table-wrap-foot><p><sup>1</sup>stimulated secretion, area under curve at OGTT with value at 0 minutes as baseline.</p></table-wrap-foot></table-wrap><table-wrap position="float" id="T2"><label>Table 2</label><caption><p>Baseline differences and carry-over effects between groups with different starting diets (mean &#x000b1; SD)</p></caption><table frame="hsides" rules="groups"><thead><tr><td></td><td align="center" colspan="2">Paleolithic diet first<break/>(7 of 13)</td><td align="center" colspan="2">Diabetes diet first<break/>(6 of 13)</td><td align="center" colspan="2">P*</td></tr><tr><td></td><td align="center">Baseline</td><td align="center">Individual mean for both diets</td><td align="center">Baseline</td><td align="center">Individual mean for both diets</td><td align="center">Baseline</td><td align="center">Carryover effect</td></tr></thead><tbody><tr><td align="left">Sex male/female (n)</td><td align="center">6/1</td><td></td><td align="center">4/2</td><td></td><td align="center">0.6</td><td></td></tr><tr><td align="left">Age (year)</td><td align="center">66 &#x000b1; 6</td><td></td><td align="center">63 &#x000b1; 6</td><td></td><td align="center">0.3</td><td></td></tr><tr><td align="left">Diabetes duration (year)</td><td align="center">6 &#x000b1; 4</td><td></td><td align="center">11 &#x000b1; 6</td><td></td><td align="center">0.13</td><td></td></tr><tr><td align="left">Diabetic values at OGTT yes/no (n)</td><td align="center">6/1</td><td></td><td align="center">6/0</td><td></td><td align="center">1.0</td><td></td></tr><tr><td align="left">Lipid lowering drug (= statin) yes/no (n)</td><td align="center">4/3</td><td></td><td align="center">4/2</td><td></td><td align="center">1.0</td><td></td></tr><tr><td align="left">Drugs per day</td><td align="center">4.9 &#x000b1; 2.7</td><td></td><td align="center">3.7 &#x000b1; 1.8</td><td></td><td align="center">0.4</td><td></td></tr><tr><td align="left">Anti-hypertensive drugs per day</td><td align="center">1.9 &#x000b1; 1.7</td><td></td><td align="center">1.2 &#x000b1; 1.2</td><td></td><td align="center">0.4</td><td></td></tr><tr><td align="left">&#x02003;Beta-blocker yes/no (n)</td><td align="center">3/7</td><td></td><td align="center">1/6</td><td></td><td align="center">1.0</td><td></td></tr><tr><td align="left">&#x02003;Thiazide yes/no (n)</td><td align="center">3/7</td><td></td><td align="center">1/6</td><td></td><td align="center">1.0</td><td></td></tr><tr><td align="left">&#x02003;ACE-inhibitor yes/no (n)</td><td align="center">3/7</td><td></td><td align="center">2/6</td><td></td><td align="center">1.0</td><td></td></tr><tr><td align="left">&#x02003;Angiotensin-II receptor blocker yes/no (n)</td><td align="center">2/7</td><td></td><td align="center">2/6</td><td></td><td align="center">1.0</td><td></td></tr><tr><td align="left">&#x02003;Calcium channel blocker yes/no (n)</td><td align="center">2/7</td><td></td><td align="center">1/7</td><td></td><td align="center">1.0</td><td></td></tr><tr><td align="left">Anti-diabetic drugs per day</td><td align="center">0.9 &#x000b1; 0.9</td><td></td><td align="center">1.5 &#x000b1; 0.8</td><td></td><td align="center">0.2</td><td></td></tr><tr><td align="left">&#x02003;Metformin yes/no (n)</td><td align="center">4/7</td><td></td><td align="center">5/6</td><td></td><td align="center">1.0</td><td></td></tr><tr><td align="left">&#x02003;Sulfonylurea yes/no (n)</td><td align="center">1/7</td><td></td><td align="center">2/6</td><td></td><td align="center">1.0</td><td></td></tr><tr><td align="left">&#x02003;Thiazolidinedione yes/no (n)</td><td align="center">1/7</td><td></td><td align="center">2/6</td><td></td><td align="center">1.0</td><td></td></tr><tr><td align="left">Metformin per day (mg)</td><td align="center">814 &#x000b1; 790</td><td></td><td align="center">1283 &#x000b1; 950</td><td></td><td align="center">0.4</td><td></td></tr><tr><td align="left">HbA1C (%, Mono-S)</td><td align="center">6.2 &#x000b1; 0.2</td><td align="center">5.4 &#x000b1; 0.5</td><td align="center">6.9 &#x000b1; 0.7</td><td align="center">6.2 &#x000b1; 0.7</td><td align="center">0.06</td><td align="center">0.04</td></tr><tr><td align="left">Cholesterol (mmol/l)</td><td align="center">4.2 &#x000b1; 1.3</td><td align="center">4.4 &#x000b1; 1.4</td><td align="center">4.7 &#x000b1; 0.9</td><td align="center">4.3 &#x000b1; 0.9</td><td align="center">0.5</td><td align="center">0.9</td></tr><tr><td align="left">LDL (mmol/l)</td><td align="center">2.7 &#x000b1; 1.0</td><td align="center">2.78 &#x000b1; 1.25</td><td align="center">3.0 &#x000b1; 0.8</td><td align="center">2.67 &#x000b1; 0.65</td><td align="center">0.6</td><td align="center">0.8</td></tr><tr><td align="left">HDL (mmol/l)</td><td align="center">1.28 &#x000b1; 0.25</td><td align="center">1.36 &#x000b1; 0.27</td><td align="center">1.28 &#x000b1; 0.19</td><td align="center">1.24 &#x000b1; 0.26</td><td align="center">1.0</td><td align="center">0.4</td></tr><tr><td align="left">TG (mmol/l)</td><td align="center">1.4 &#x000b1; 0.5</td><td align="center">1.1 &#x000b1; 0.4</td><td align="center">1.7 &#x000b1; 0.8</td><td align="center">1.4 &#x000b1; 0.7</td><td align="center">0.5</td><td align="center">0.3</td></tr><tr><td align="left">CRP (mg/l)</td><td align="center">2.9 &#x000b1; 2.2</td><td align="center">2.2 &#x000b1; 1.6</td><td align="center">1.9 &#x000b1; 1.3</td><td align="center">2.4 &#x000b1; 1.5</td><td align="center">0.4</td><td align="center">0.9</td></tr><tr><td align="left">SBP (mmHg)</td><td align="center">156 &#x000b1; 23</td><td align="center">148 &#x000b1; 14</td><td align="center">144 &#x000b1; 18</td><td align="center">141 &#x000b1; 17</td><td align="center">0.3</td><td align="center">0.4</td></tr><tr><td align="left">DBP (mmHg)</td><td align="center">83 &#x000b1; 11</td><td align="center">80 &#x000b1; 8</td><td align="center">84 &#x000b1; 9</td><td align="center">82 &#x000b1; 7</td><td align="center">0.8</td><td align="center">0.6</td></tr><tr><td align="left">Height (cm)</td><td align="center">172 &#x000b1; 4</td><td></td><td align="center">170 &#x000b1; 6</td><td></td><td align="center">0.6</td><td></td></tr><tr><td align="left">Weight (kg)</td><td align="center">82 &#x000b1; 13</td><td align="center">77 &#x000b1; 11</td><td align="center">92 &#x000b1; 20</td><td align="center">88 &#x000b1; 15</td><td align="center">0.3</td><td align="center">0.2</td></tr><tr><td align="left">BMI (kg/m<sup>2</sup>)</td><td align="center">28 &#x000b1; 4</td><td align="center">26 &#x000b1; 3</td><td align="center">32 &#x000b1; 8</td><td align="center">31 &#x000b1; 6</td><td align="center">0.3</td><td align="center">0.14</td></tr><tr><td align="left">Waist (cm)</td><td align="center">97 &#x000b1; 9</td><td align="center">92 &#x000b1; 8</td><td align="center">109 &#x000b1; 17</td><td align="center">101 &#x000b1; 10</td><td align="center">0.2</td><td align="center">0.10</td></tr><tr><td align="left">fP-glucose (mmol/l)</td><td align="center">7.1 &#x000b1; 0.7</td><td align="center">6.6 &#x000b1; 1.1</td><td align="center">8.6 &#x000b1; 1.2</td><td align="center">8.0 &#x000b1; 1.3</td><td align="center">0.02</td><td align="center">0.052</td></tr><tr><td align="left">fP-insulin (pmol/l)</td><td align="center">118 &#x000b1; 53</td><td align="center">64 &#x000b1; 19</td><td align="center">75 &#x000b1; 12</td><td align="center">73 &#x000b1; 23</td><td align="center">0.07</td><td align="center">0.5</td></tr><tr><td align="left">AUC glucose<sub>0&#x02013;120 </sub>(mmol/l&#x000b7;min)</td><td align="center">1498 &#x000b1; 227</td><td align="center">1321 &#x000b1; 310</td><td align="center">1734 &#x000b1; 128</td><td align="center">1574 &#x000b1; 289</td><td align="center">0.046</td><td align="center">0.2</td></tr><tr><td align="left">AUC glucose<sub>0&#x02013;120 </sub>(mmol/l&#x000b7;min)<sup>1</sup></td><td align="center">642 &#x000b1; 165</td><td align="center">534 &#x000b1; 205</td><td align="center">698 &#x000b1; 219</td><td align="center">613 &#x000b1; 155</td><td align="center">0.6</td><td align="center">0.5</td></tr><tr><td align="left">AUC insulin<sub>0&#x02013;120 </sub>(nmol/l&#x000b7;min)</td><td align="center">35 &#x000b1; 13</td><td align="center">29 &#x000b1; 11</td><td align="center">24 &#x000b1; 8</td><td align="center">24 &#x000b1; 15</td><td align="center">0.13</td><td align="center">0.5</td></tr><tr><td align="left">AUC insulin<sub>0&#x02013;120 </sub>(nmol/l&#x000b7;min)<sup>1</sup></td><td align="center">20 &#x000b1; 8</td><td align="center">21 &#x000b1; 10</td><td align="center">15 &#x000b1; 9</td><td align="center">15 &#x000b1; 13</td><td align="center">0.3</td><td align="center">0.4</td></tr><tr><td align="left">ISI<sub>0,120 </sub>(mg&#x000b7;l<sup>2</sup>/mmol&#x000b7;mU&#x000b7;min)</td><td align="center">44 &#x000b1; 11</td><td align="center">55 &#x000b1; 21</td><td align="center">36 &#x000b1; 3</td><td align="center">52 &#x000b1; 19</td><td align="center">0.11</td><td align="center">0.8</td></tr><tr><td align="left">HOMA2 %B</td><td align="center">83 &#x000b1; 36</td><td align="center">67 &#x000b1; 23</td><td align="center">43 &#x000b1; 11</td><td align="center">49 &#x000b1; 15</td><td align="center">0.03</td><td align="center">0.14</td></tr><tr><td align="left">HOMA2 %S</td><td align="center">54 &#x000b1; 35</td><td align="center">92 &#x000b1; 30</td><td align="center">65 &#x000b1; 12</td><td align="center">74 &#x000b1; 25</td><td align="center">0.4</td><td align="center">0.3</td></tr><tr><td align="left">HOMA2 IR</td><td align="center">2.4 &#x000b1; 1.0</td><td align="center">1.3 &#x000b1; 0.4</td><td align="center">1.6 &#x000b1; 0.3</td><td align="center">1.5 &#x000b1; 0.5</td><td align="center">0.09</td><td align="center">0.3</td></tr></tbody></table><table-wrap-foot><p>Baseline differences and carry-over effects between groups randomized to start with Paleolithic diet first or Diabetes diet first (mean &#x000b1; SD). Carry-over effect tested for on individual means for both diets ((Paleolithic diet plus Diabetes diet)/2). *P for difference between groups with different starting diets in a two-sided t-test with independent samples, except for categorically reported values for sex, diabetic values at OGTT and drug treatment (e.g. lipid lowering drug), where P is for difference in Fisher's exact two-sided test with independent samples. <sup>1</sup>stimulated secretion, area under curve at OGTT with value at 0 minutes as baseline.</p></table-wrap-foot></table-wrap><p>One participant stopped taking sulfonylurea (glibencklamide 87.5 mg daily) the day after starting the study with the Paleolithic diet, and was thus on a low dose sulfonylurea at baseline, but without sulfonylurea during both the Paleolithic and Diabetes diet. Exclusion of this participant would not negate any significant effects from the Paleolithic diet compared to the Diabetes diet, but would negate the effect from the Paleolithic diet compared to baseline on systolic blood pressure, and the effect from the Diabetes diet compared to baseline on BMI. Due to concerns for rising blood sugar levels one participant switched hypertensive treatment from a thiazide diuretic to a beta blocker for seven weeks during the Paleolithic diet. Exclusion of this participant would not negate the significant effect on HbA1c, but would negate the effect on diastolic blood pressure. Due to concerns about muscle ache one participant was without lipid-lowering drug treatment for four weeks during the Paleolithic diet. Exclusion of this participant would not negate the significant effects on TG and HDL, but would instead cause also total cholesterol to be significantly lower following the Paleolithic diet compared to the Diabetes diet (<italic>p </italic>= 0.03). One participant was put on finasteride (5 mg daily, a drug versus benign prostate hyperplasia) during the Paleolithic diet and continued this medication during the following Diabetes diet.</p></sec><sec><title>Baseline data</title><p>The group starting with the Paleolithic diet differed at baseline only with regard to fasting plasma glucose and AUC glucose being lower and HOMA2 %B being higher compared to the group starting with a Diabetes diet (Table <xref ref-type="table" rid="T2">2</xref>). There was no difference between starting groups before or at the end of the study in inclusion/exclusion variables.</p></sec><sec><title>Outcome variables</title><p>Compared to the Diabetes diet, the Paleolithic diet resulted in lower mean values of HbA1c, TG, DBP, weight, BMI and waist circumference, while mean values for HDL were higher (Table <xref ref-type="table" rid="T3">3</xref>, Figure <xref ref-type="fig" rid="F1">1</xref>). The larger decrease of fasting plasma glucose following the Paleolithic diet nearly reached significance, and SBP also tended to decrease more following the Paleolithic diet. Compared to baseline, the Paleolithic diet lowered mean values of HbA1c, TG, SBP, weight, BMI, waist circumference, fasting plasma glucose, fasting plasma insulin, AUC glucose, ISI<sub>0,120</sub>, HOMA2 %S and HOMA2 %IR (Table <xref ref-type="table" rid="T3">3</xref>). Compared to baseline, the Diabetes diet lowered mean values of BMI, waist circumference and HOMA2 %S (Table <xref ref-type="table" rid="T3">3</xref>). Period effects were seen in AUC insulin<sub>0&#x02013;120</sub>, AUC insulin<sub>0&#x02013;120 </sub>stimulated secretion and HOMA2 %B (Table <xref ref-type="table" rid="T4">4</xref>). Carry over effects were seen in HbA1c (Table <xref ref-type="table" rid="T2">2</xref>, Figure <xref ref-type="fig" rid="F1">1</xref>).</p><table-wrap position="float" id="T3"><label>Table 3</label><caption><p>Risk factors for cardiovascular disease after Paleolithic diet and Diabetes diet (mean &#x000b1; SD, Confidence Interval 95%)</p></caption><table frame="hsides" rules="groups"><thead><tr><td></td><td align="center">Paleolithic diet</td><td align="left">P*</td><td align="center">Diabetes diet</td><td align="left">P**</td><td align="center">Delta diets<sup>1</sup></td><td align="left">P***</td></tr></thead><tbody><tr><td align="left">HbA1C (%, Mono-S)</td><td align="center">5.5 &#x000b1; 0.7, 5.1 to 5.9</td><td align="left">0.0001</td><td align="center">5.9 &#x000b1; 0.9, 5.5 to 6.4</td><td align="left">0.001</td><td align="center">-0.4</td><td align="left">0.02</td></tr><tr><td align="left">Cholesterol (mmol/l)</td><td align="center">4.3 &#x000b1; 1.2, 3.6 to 4.9</td><td align="left">0.6</td><td align="center">4.5 &#x000b1; 1.2, 3.8 to 5.1</td><td align="left">0.7</td><td align="center">-0.2</td><td align="left">0.3</td></tr><tr><td align="left">LDL (mmol/l)</td><td align="center">2.7 &#x000b1; 1.0, 2.1 to 3.2</td><td align="left">0.3</td><td align="center">2.8 &#x000b1; 1.1, 2.2 to 3.4</td><td align="left">0.6</td><td align="center">-0.1</td><td align="left">0.5</td></tr><tr><td align="left">HDL (mmol/l)</td><td align="center">1.34 &#x000b1; 0.30, 1.18 to 1.51</td><td align="left">0.2</td><td align="center">1.26 &#x000b1; 0.23, 1.14 to 1.39</td><td align="left">0.7</td><td align="center">0.08</td><td align="left">0.03</td></tr><tr><td align="left">TG (mmol/l)</td><td align="center">1.0 &#x000b1; 0.5, 0.8 to 1.3</td><td align="left">0.003</td><td align="center">1.5 &#x000b1; 0.7, 1.1 to 1.8</td><td align="left">0.7</td><td align="center">-0.4</td><td align="left">0.003</td></tr><tr><td align="left">CRP (mg/l)</td><td align="center">2.0 &#x000b1; 1.6, 1.1 to 2.9</td><td align="left">0.2</td><td align="center">2.6 &#x000b1; 2.3, 1.4 to 3.8</td><td align="left">0.8</td><td align="center">-0.6</td><td align="left">0.4</td></tr><tr><td align="left">SBP (mmHg)</td><td align="center">140 &#x000b1; 12, 134 to 147</td><td align="left">0.048</td><td align="center">149 &#x000b1; 22, 137 to 161</td><td align="left">0.7</td><td align="center">-8</td><td align="left">0.13</td></tr><tr><td align="left">DBP (mmHg)</td><td align="center">79 &#x000b1; 6, 76 to 82</td><td align="left">0.06</td><td align="center">83 &#x000b1; 9, 78 to 88</td><td align="left">0.7</td><td align="center">-4</td><td align="left">0.03</td></tr><tr><td align="left">Weight (kg)</td><td align="center">81 &#x000b1; 13, 74 to 88</td><td align="left">0.005</td><td align="center">84 &#x000b1; 15, 76 to 92</td><td align="left">0.052</td><td align="center">-3</td><td align="left">0.01</td></tr><tr><td align="left">BMI (kg/m<sup>2</sup>)</td><td align="center">28 &#x000b1; 5, 25 to 30</td><td align="left">0.01</td><td align="center">29 &#x000b1; 6, 26 to 32</td><td align="left">0.03</td><td align="center">-1</td><td align="left">0.04</td></tr><tr><td align="left">Waist (cm)</td><td align="center">94 &#x000b1; 9, 89 to 99</td><td align="left">0.01</td><td align="center">98 &#x000b1; 11, 92 to 104</td><td align="left">0.02</td><td align="center">-4</td><td align="left">0.02</td></tr><tr><td align="left">fP-glucose (mmol/l)</td><td align="center">7.0 &#x000b1; 1.4, 6.2 to 7.8</td><td align="left">0.01</td><td align="center">7.5 &#x000b1; 1.4, 6.7 to 8.2</td><td align="left">0.2</td><td align="center">-0.5</td><td align="left">0.08</td></tr><tr><td align="left">fP-insulin (pmol/l)</td><td align="center">69 &#x000b1; 30, 53 to 85</td><td align="left">0.02</td><td align="center">67 &#x000b1; 20, 57 to 78</td><td align="left">0.06</td><td align="center">2</td><td align="left">0.8</td></tr><tr><td align="left">AUC glucose<sub>0&#x02013;120 </sub>(mmol/l&#x000b7;min)</td><td align="center">1398 &#x000b1; 314, 1227 to 1568</td><td align="left">0.01</td><td align="center">1478 &#x000b1; 358, 1283 to 1672</td><td align="left">0.09</td><td align="center">-80</td><td align="left">0.2</td></tr><tr><td align="left">AUC glucose<sub>0&#x02013;120 </sub>(mmol/l&#x000b7;min)<sup>2</sup></td><td align="center">558 &#x000b1; 196, 452 to 665</td><td align="left">0.09</td><td align="center">582 &#x000b1; 213, 467 to 698</td><td align="left">0.2</td><td align="center">-24</td><td align="left">0.7</td></tr><tr><td align="left">AUC insulin<sub>0&#x02013;120 </sub>(nmol/l&#x000b7;min)</td><td align="center">26 &#x000b1; 14, 19 to 34</td><td align="left">0.10</td><td align="center">27 &#x000b1; 13, 20 to 34</td><td align="left">0.4</td><td align="center">0</td><td align="left">0.9</td></tr><tr><td align="left">AUC insulin<sub>0&#x02013;120 </sub>(nmol/l&#x000b7;min)<sup>2</sup></td><td align="center">18 &#x000b1; 13, 11 to 25</td><td align="left">0.9</td><td align="center">19 &#x000b1; 11, 12 to 25</td><td align="left">0.8</td><td align="center">-1</td><td align="left">0.7</td></tr><tr><td align="left">ISI<sub>0,120 </sub>(mg&#x000b7;l<sup>2</sup>/mmol&#x000b7;mU&#x000b7;min)</td><td align="center">56 &#x000b1; 22, 44 to 68</td><td align="left">0.02</td><td align="center">50 &#x000b1; 20, 40 to 61</td><td align="left">0.052</td><td align="center">6</td><td align="left">0.2</td></tr><tr><td align="left">HOMA2 %B</td><td align="center">63 &#x000b1; 27, 48 to 77</td><td align="left">0.6</td><td align="center">55 &#x000b1; 19, 44 to 66</td><td align="left">0.2</td><td align="center">8</td><td align="left">0.2</td></tr><tr><td align="left">HOMA2 %S</td><td align="center">89 &#x000b1; 45, 64 to 113</td><td align="left">0.02</td><td align="center">79 &#x000b1; 23, 66 to 91</td><td align="left">0.04</td><td align="center">10</td><td align="left">0.4</td></tr><tr><td align="left">HOMA2 IR</td><td align="center">1.4 &#x000b1; 0.6, 1.1 to 1.7</td><td align="left">0.01</td><td align="center">1.4 &#x000b1; 0.4, 1.1 to 1.6</td><td align="left">0.052</td><td align="center">0</td><td align="left">0.9</td></tr><tr><td align="left">Diabetic values at OGTT yes/no (n)</td><td align="center">8/5</td><td align="left">0.13</td><td align="center">9/4</td><td align="left">0.3</td><td align="center">-1/1</td><td align="left">1.0</td></tr></tbody></table><table-wrap-foot><p>Risk factors for cardiovascular disease after 3 months of Paleolithic diet compared to 3 months of Diabetes diet (mean&#x000b1;SD, Confidence Interval 95%). <sup>1</sup>Mean value for Paleolithic diet minus mean value for Diabetes diet. All P-values from two-sided t-test  with dependent samples, except for Diabetic values at OGTT where P is for difference  between diets in Fischer's two-sided exact test with related samples. *P for difference  between Paleolithic diet and baseline, **P for difference between Diabetes diet and  baseline and ***P for difference between diets. <sup>2</sup>Stimulated secretion, area under  curve at OGTT with value at 0 minutes as baseline.</p></table-wrap-foot></table-wrap><table-wrap position="float" id="T4"><label>Table 4</label><caption><p>Period effects on cardiovascular risk factors after 3 and 6 months in all 13 subjects combined (mean &#x000b1; SD)</p></caption><table frame="hsides" rules="groups"><thead><tr><td></td><td align="center">Baseline</td><td align="center">3 months</td><td align="center">6 months</td><td align="left">P*</td></tr></thead><tbody><tr><td align="left">HbA1C (%, Mono-S)</td><td align="center">6.6 &#x000b1; 0.6</td><td align="center">5.9 &#x000b1; 0.9</td><td align="center">5.6 &#x000b1; 0.6</td><td align="left">0.10</td></tr><tr><td align="left">Cholesterol (mmol/l)</td><td align="center">4.4 &#x000b1; 1.1</td><td align="center">4.4 &#x000b1; 1.1</td><td align="center">4.3 &#x000b1; 1.3</td><td align="left">0.6</td></tr><tr><td align="left">LDL (mmol/l)</td><td align="center">2.9 &#x000b1; 0.9</td><td align="center">2.8 &#x000b1; 1.0</td><td align="center">2.7 &#x000b1; 1.0</td><td align="left">0.5</td></tr><tr><td align="left">HDL (mmol/l)</td><td align="center">1.3 &#x000b1; 0.2</td><td align="center">1.3 &#x000b1; 0.3</td><td align="center">1.3 &#x000b1; 0.3</td><td align="left">0.9</td></tr><tr><td align="left">TG (mmol/l)</td><td align="center">1.5 &#x000b1; 0.7</td><td align="center">1.3 &#x000b1; 0.7</td><td align="center">1.2 &#x000b1; 0.5</td><td align="left">0.5</td></tr><tr><td align="left">CRP (mg/l)</td><td align="center">2.4 &#x000b1; 1.8</td><td align="center">2.8 &#x000b1; 2.5</td><td align="center">1.8 &#x000b1; 1.0</td><td align="left">0.14</td></tr><tr><td align="left">SBP (mmHg)</td><td align="center">150 &#x000b1; 21</td><td align="center">144 &#x000b1; 16</td><td align="center">145 &#x000b1; 21</td><td align="left">0.9</td></tr><tr><td align="left">DBP (mmHg)</td><td align="center">83 &#x000b1; 8</td><td align="center">80 &#x000b1; 8</td><td align="center">82 &#x000b1; 8</td><td align="left">0.4</td></tr><tr><td align="left">Weight (kg)</td><td align="center">87 &#x000b1; 17</td><td align="center">83 &#x000b1; 15</td><td align="center">82 &#x000b1; 12</td><td align="left">0.4</td></tr><tr><td align="left">BMI (kg/m<sup>2</sup>)</td><td align="center">30 &#x000b1; 7</td><td align="center">29 &#x000b1; 6</td><td align="center">28 &#x000b1; 4</td><td align="left">0.4</td></tr><tr><td align="left">Waist (cm)</td><td align="center">103 &#x000b1; 14</td><td align="center">96.8 &#x000b1; 12</td><td align="center">95 &#x000b1; 9</td><td align="left">0.5</td></tr><tr><td align="left">fP-glucose (mmol/l)</td><td align="center">7.8 &#x000b1; 1.2</td><td align="center">7.1 &#x000b1; 1.6</td><td align="center">7.3 &#x000b1; 1.3</td><td align="left">0.5</td></tr><tr><td align="left">fP-insulin (pmol/l)</td><td align="center">98 &#x000b1; 44</td><td align="center">74 &#x000b1; 28</td><td align="center">63 &#x000b1; 21</td><td align="left">0.2</td></tr><tr><td align="left">AUC glucose (mmol/l&#x000b7;min)</td><td align="center">1607 &#x000b1; 218</td><td align="center">1438 &#x000b1; 350</td><td align="center">1437 &#x000b1; 329</td><td align="left">1.0</td></tr><tr><td align="left">AUC glucose (mmol/l&#x000b7;min)<sup>1</sup></td><td align="center">667 &#x000b1; 186</td><td align="center">583 &#x000b1; 189</td><td align="center">558 &#x000b1; 219</td><td align="left">0.6</td></tr><tr><td align="left">AUC insulin (nmol/l&#x000b7;min)</td><td align="center">30 &#x000b1; 12</td><td align="center">29 &#x000b1; 12</td><td align="center">23 &#x000b1; 14</td><td align="left">0.01</td></tr><tr><td align="left">AUC insulin (nmol/l&#x000b7;min)<sup>1</sup></td><td align="center">18 &#x000b1; 8</td><td align="center">21 &#x000b1; 11</td><td align="center">16 &#x000b1; 13</td><td align="left">0.01</td></tr><tr><td align="left">ISI<sub>0,120 </sub>(mg&#x000b7;l<sup>2</sup>/mmol&#x000b7;mU&#x000b7;min)</td><td align="center">40 &#x000b1; 9</td><td align="center">50 &#x000b1; 16</td><td align="center">56 &#x000b1; 25</td><td align="left">0.2</td></tr><tr><td align="left">HOMA2 %B</td><td align="center">65 &#x000b1; 34</td><td align="center">65 &#x000b1; 27</td><td align="center">53 &#x000b1; 18</td><td align="left">0.04</td></tr><tr><td align="left">HOMA2 %S</td><td align="center">59 &#x000b1; 27</td><td align="center">80 &#x000b1; 42</td><td align="center">87 &#x000b1; 28</td><td align="left">0.6</td></tr><tr><td align="left">HOMA2 IR</td><td align="center">2.0 &#x000b1; 0.8</td><td align="center">1.5 &#x000b1; 0.6</td><td align="center">1.3 &#x000b1; 0.4</td><td align="left">0.2</td></tr><tr><td align="left">Diabetic values at OGTT yes/no (n)</td><td align="center">12/1</td><td align="center">8/5</td><td align="center">9/4</td><td align="left">1.0</td></tr></tbody></table><table-wrap-foot><p>*P for difference between 3 and 6 months in a two-sided t-test with dependent samples, except for Diabetic values at OGTT where P is for difference between diets in Fischer's two-sided exact test with related samples. <sup>1</sup>stimulated secretion, area under curve at OGTT with value at 0 minutes as baseline.</p></table-wrap-foot></table-wrap><fig position="float" id="F1"><label>Figure 1</label><caption><p><bold>Cardiovascular risk factors with significant effects from Paleolithic diet compared to Diabetes diet</bold>. Closed circles depicts individuals starting with Diabetes diet first and open circles depicts individuals starting with Paleolithic diet first. Values are group means and error bars depicts SD for group means.</p></caption><graphic xlink:href="1475-2840-8-35-1"/></fig></sec><sec><title>Reported food intake</title><p>There were no period or carry-over effects in reported dietary intakes (data not shown). Reported daily food intake differed between diets mainly in that the Paleolithic diet was markedly lower in cereals and dairy products, and lower in potatoes, beans and bakery, and much higher in fruits, vegetables, meat and eggs (Table <xref ref-type="table" rid="T5">5</xref>). Further, the Paleolithic diet was somewhat lower in total energy, energy density, carbohydrate, fiber, saturated fatty acids and calcium, and higher in monosaccharides, dietary cholesterol, some vitamins (vitamin B6, vitamin C, niacin) and minerals (potassium, selenium) (Table <xref ref-type="table" rid="T5">5</xref>). During the Paleolithic diet, there was a lower relative intake (as a percentage of total macronutrient energy intake [E%]) of carbohydrate and a higher relative intake of protein and fat (Table <xref ref-type="table" rid="T5">5</xref>). Both dietary GL and dietary GI were determined to be lower for the Paleolithic diet than for the Diabetic diet (Table <xref ref-type="table" rid="T5">5</xref>).</p><table-wrap position="float" id="T5"><label>Table 5</label><caption><p>Average food eaten per day during Paleolithic diet and Diabetes diet (mean &#x000b1; SD)</p></caption><table frame="hsides" rules="groups"><thead><tr><td></td><td align="center">Paleolithic</td><td align="center">Diabetes</td><td align="left">P*</td></tr></thead><tbody><tr><td align="left">Total weight (g)</td><td align="center">1445 &#x000b1; 367</td><td align="center">1456 &#x000b1; 312</td><td align="left">0.9</td></tr><tr><td align="left">Total energy (MJ)</td><td align="center">6.6 &#x000b1; 1.2</td><td align="center">7.9 &#x000b1; 1.6</td><td align="left">0.005</td></tr><tr><td align="left">(kcal)</td><td align="center">1581 &#x000b1; 295</td><td align="center">1878 &#x000b1; 379</td><td align="left">0.005</td></tr><tr><td align="left">Energy density (kJ/g)</td><td align="center">4.7 &#x000b1; 0.7</td><td align="center">5.6 &#x000b1; 1.1</td><td align="left">0.02</td></tr><tr><td align="left">Protein (g)</td><td align="center">94 &#x000b1; 18</td><td align="center">90 &#x000b1; 14</td><td align="left">0.5</td></tr><tr><td align="left">(E%)</td><td align="center">24 &#x000b1; 3</td><td align="center">20 &#x000b1; 4</td><td align="left">0.0001</td></tr><tr><td align="left">Carbohydrate (g)</td><td align="center">125 &#x000b1; 43</td><td align="center">196 &#x000b1; 61</td><td align="left">0.00001</td></tr><tr><td align="left">(E%)</td><td align="center">32 &#x000b1; 7</td><td align="center">42 &#x000b1; 7</td><td align="left">0.0001</td></tr><tr><td align="left">Fat (g)</td><td align="center">68 &#x000b1; 11</td><td align="center">72 &#x000b1; 20</td><td align="left">0.6</td></tr><tr><td align="left">(E%)</td><td align="center">39 &#x000b1; 5</td><td align="center">34 &#x000b1; 6</td><td align="left">0.04</td></tr><tr><td align="left">Alcohol (g)</td><td align="center">6.3 &#x000b1; 8.9</td><td align="center">3.6 &#x000b1; 5.6</td><td align="left">0.2</td></tr><tr><td align="left">(E%)</td><td align="center">3 &#x000b1; 4</td><td align="center">1 &#x000b1; 2</td><td align="left">0.08</td></tr><tr><td align="left">Fiber (g)</td><td align="center">21 &#x000b1; 8</td><td align="center">26 &#x000b1; 8</td><td align="left">0.02</td></tr><tr><td align="left">(E%)</td><td align="center">2.5 &#x000b1; 0.7</td><td align="center">2.7 &#x000b1; 0.7</td><td align="left">0.4</td></tr><tr><td align="left">Glycemic Load (g)</td><td align="center">63 &#x000b1; 23</td><td align="center">111 &#x000b1; 41</td><td align="left">0.00002</td></tr><tr><td align="left">Glycemic Index</td><td align="center">50 &#x000b1; 5</td><td align="center">55 &#x000b1; 6</td><td align="left">0.01</td></tr><tr><td align="left">Monosaccharides (g)</td><td align="center">46 &#x000b1; 21</td><td align="center">33 &#x000b1; 16</td><td align="left">0.03</td></tr><tr><td align="left">Disaccharides(g)</td><td align="center">31 &#x000b1; 14</td><td align="center">39 &#x000b1; 15</td><td align="left">0.10</td></tr><tr><td align="left">Sucrose (g)</td><td align="center">29 &#x000b1; 13</td><td align="center">30 &#x000b1; 12</td><td align="left">0.8</td></tr><tr><td align="left">Saturated fatty acid (g)</td><td align="center">19 &#x000b1; 5</td><td align="center">27 &#x000b1; 9</td><td align="left">0.002</td></tr><tr><td align="left">Monounsaturated fatty acid(g)</td><td align="center">30 &#x000b1; 6</td><td align="center">26 &#x000b1; 7</td><td align="left">0.13</td></tr><tr><td align="left">Polyunsaturated fatty acid (g)</td><td align="center">14 &#x000b1; 4</td><td align="center">12 &#x000b1; 4</td><td align="left">0.2</td></tr><tr><td align="left">Fatty acid C4:0-C10:0 (g)</td><td align="center">0.3 &#x000b1; 0.4</td><td align="center">2.1 &#x000b1; 1.3</td><td align="left">0.0001</td></tr><tr><td align="left">Fatty acid C12:0 (g)</td><td align="center">0.3 &#x000b1; 0.3</td><td align="center">1.1 &#x000b1; 0.8</td><td align="left">0.002</td></tr><tr><td align="left">Fatty acid C14:0 (g)</td><td align="center">1.3 &#x000b1; 0.5</td><td align="center">2.8 &#x000b1; 1.3</td><td align="left">0.0002</td></tr><tr><td align="left">Fatty acid C16:0 (g)</td><td align="center">12 &#x000b1; 3</td><td align="center">14 &#x000b1; 4</td><td align="left">0.02</td></tr><tr><td align="left">Fatty acid C16:1 (g)</td><td align="center">2.0 &#x000b1; 0.5</td><td align="center">1.5 &#x000b1; 0.6</td><td align="left">0.03</td></tr><tr><td align="left">Fatty acid C18:0 (g)</td><td align="center">4.5 &#x000b1; 1.5</td><td align="center">5.9 &#x000b1; 1.9</td><td align="left">0.053</td></tr><tr><td align="left">Fatty acid C18:1, oleic acid (g)</td><td align="center">26 &#x000b1; 6</td><td align="center">24 &#x000b1; 7</td><td align="left">0.3</td></tr><tr><td align="left">Fatty acid C18:2, n-6, Linoleic acid (g)</td><td align="center">9 &#x000b1; 4</td><td align="center">8 &#x000b1; 3</td><td align="left">0.6</td></tr><tr><td align="left">Fatty acid C18:3, n-3, ALA (g)</td><td align="center">1.5 &#x000b1; 0.7</td><td align="center">1.6 &#x000b1; 0.8</td><td align="left">0.6</td></tr><tr><td align="left">Fatty acid C20:0 (g)</td><td align="center">0.1 &#x000b1; 0.1</td><td align="center">0.1 &#x000b1; 0.1</td><td align="left">0.2</td></tr><tr><td align="left">Fatty acid C20:4, n-6 (g)</td><td align="center">0.2 &#x000b1; 0.1</td><td align="center">0.1 &#x000b1; 0.1</td><td align="left">0.01</td></tr><tr><td align="left">Fatty acid C20:5, n-3, EPA (g)</td><td align="center">0.6 &#x000b1; 0.3</td><td align="center">0.3 &#x000b1; 0.3</td><td align="left">0.052</td></tr><tr><td align="left">Fatty acid C22:5, n-3 (g)</td><td align="center">0.2 &#x000b1; 0.1</td><td align="center">0.1 &#x000b1; 0.1</td><td align="left">0.3</td></tr><tr><td align="left">Fatty acid C22:6, n-3, DHA (g)</td><td align="center">1.3 &#x000b1; 0.7</td><td align="center">0.7 &#x000b1; 0.7</td><td align="left">0.06</td></tr><tr><td align="left">Cholesterol (mg)</td><td align="center">577 &#x000b1; 107</td><td align="center">365 &#x000b1; 88</td><td align="left">0.0003</td></tr><tr><td align="left">Vitamin A, Retinolequivalents (&#x003bc;g)</td><td align="center">896 &#x000b1; 534</td><td align="center">1139 &#x000b1; 450</td><td align="left">0.2</td></tr><tr><td align="left">Vitamin A, Retinol (&#x003bc;g)</td><td align="center">385 &#x000b1; 333</td><td align="center">673 &#x000b1; 353</td><td align="left">0.051</td></tr><tr><td align="left">Vitamin A, Caroten (&#x003bc;g)</td><td align="center">5038 &#x000b1; 3414</td><td align="center">4811 &#x000b1; 5633</td><td align="left">0.9</td></tr><tr><td align="left">Vitamin D (&#x003bc;g)</td><td align="center">9 &#x000b1; 4</td><td align="center">9 &#x000b1; 7</td><td align="left">0.9</td></tr><tr><td align="left">Vitamin E (mg)</td><td align="center">13 &#x000b1; 4</td><td align="center">11 &#x000b1; 3</td><td align="left">0.07</td></tr><tr><td align="left">Vitamin E, Alpha-tocopherol (mg)</td><td align="center">13 &#x000b1; 4</td><td align="center">11 &#x000b1; 3</td><td align="left">0.07</td></tr><tr><td align="left">Vitamin B-1, Thiamin (mg)</td><td align="center">1.5 &#x000b1; 0.5</td><td align="center">1.6 &#x000b1; 0.5</td><td align="left">0.8</td></tr><tr><td align="left">Vitamin B-2, Riboflavin (mg)</td><td align="center">1.6 &#x000b1; 0.3</td><td align="center">1.6 &#x000b1; 0.2</td><td align="left">0.5</td></tr><tr><td align="left">Vitamin B-6 (mg)</td><td align="center">3.2 &#x000b1; 0.7</td><td align="center">2.4 &#x000b1; 0.6</td><td align="left">0.003</td></tr><tr><td align="left">Vitamin B-12 (&#x003bc;g)</td><td align="center">8.6 &#x000b1; 4.0</td><td align="center">6.7 &#x000b1; 2.4</td><td align="left">0.2</td></tr><tr><td align="left">Vitamin B, Folate (&#x003bc;g)</td><td align="center">340 &#x000b1; 172</td><td align="center">300 &#x000b1; 79</td><td align="left">0.4</td></tr><tr><td align="left">Vitamin C, Ascorbic acid (mg)</td><td align="center">219 &#x000b1; 136</td><td align="center">119 &#x000b1; 60</td><td align="left">0.03</td></tr><tr><td align="left">Niacinequivalents (mg)</td><td align="center">45 &#x000b1; 11</td><td align="center">39 &#x000b1; 8</td><td align="left">0.08</td></tr><tr><td align="left">Niacin (mg)</td><td align="center">27 &#x000b1; 8</td><td align="center">22 &#x000b1; 6</td><td align="left">0.03</td></tr><tr><td align="left">Phosphorus (mg)</td><td align="center">1233 &#x000b1; 247</td><td align="center">1437 &#x000b1; 208</td><td align="left">0.02</td></tr><tr><td align="left">Iron (mg)</td><td align="center">12 &#x000b1; 3</td><td align="center">12 &#x000b1; 3</td><td align="left">1.0</td></tr><tr><td align="left">Potassium (mg)</td><td align="center">3669 &#x000b1; 982</td><td align="center">3181 &#x000b1; 908</td><td align="left">0.0497</td></tr><tr><td align="left">Calcium (mg)</td><td align="center">356 &#x000b1; 102</td><td align="center">698 &#x000b1; 220</td><td align="left">0.00002</td></tr><tr><td align="left">Magnesium (mg)</td><td align="center">307 &#x000b1; 84</td><td align="center">311 &#x000b1; 68</td><td align="left">0.9</td></tr><tr><td align="left">Sodium (mg)</td><td align="center">2530 &#x000b1; 924</td><td align="center">2963 &#x000b1; 678</td><td align="left">0.14</td></tr><tr><td align="left">Selenium (&#x003bc;g)</td><td align="center">81 &#x000b1; 20</td><td align="center">55 &#x000b1; 18</td><td align="left">0.001</td></tr><tr><td align="left">Zinc (mg)</td><td align="center">11 &#x000b1; 3</td><td align="center">12 &#x000b1; 2</td><td align="left">0.3</td></tr><tr><td align="left">Ash (g)</td><td align="center">17 &#x000b1; 4</td><td align="center">19 &#x000b1; 4</td><td align="left">0.13</td></tr><tr><td align="left">Water (g)</td><td align="center">1113 &#x000b1; 306</td><td align="center">1049 &#x000b1; 258</td><td align="left">0.5</td></tr><tr><td align="left">Fruits (g)</td><td align="center">451 &#x000b1; 200</td><td align="center">251 &#x000b1; 210</td><td align="left">0.005</td></tr><tr><td align="left">Vegetables (g)</td><td align="center">346 &#x000b1; 179</td><td align="center">241 &#x000b1; 176</td><td align="left">0.0497</td></tr><tr><td align="left">Potatoes (g)</td><td align="center">49 &#x000b1; 51</td><td align="center">106 &#x000b1; 84</td><td align="left">0.03</td></tr><tr><td align="left">Nuts (g)</td><td align="center">29 &#x000b1; 24</td><td align="center">12 &#x000b1; 20</td><td align="left">0.13</td></tr><tr><td align="left">Meat (g)</td><td align="center">139 &#x000b1; 67</td><td align="center">73 &#x000b1; 29</td><td align="left">0.003</td></tr><tr><td align="left">Meat products (g)</td><td align="center">97 &#x000b1; 76</td><td align="center">71 &#x000b1; 43</td><td align="left">0.2</td></tr><tr><td align="left">Fish (g)</td><td align="center">104 &#x000b1; 55</td><td align="center">89 &#x000b1; 56</td><td align="left">0.5</td></tr><tr><td align="left">Eggs (g)</td><td align="center">71 &#x000b1; 27</td><td align="center">27 &#x000b1; 24</td><td align="left">0.001</td></tr><tr><td align="left">Beans (g)</td><td align="center">4 &#x000b1; 14</td><td align="center">24 &#x000b1; 33</td><td align="left">0.03</td></tr><tr><td align="left">Cereals without rice (g)</td><td align="center">11 &#x000b1; 24</td><td align="center">172 &#x000b1; 96</td><td align="left">0.00004</td></tr><tr><td align="left">Rice (g)</td><td align="center">7 &#x000b1; 17</td><td align="center">6 &#x000b1; 10</td><td align="left">0.9</td></tr><tr><td align="left">Milk/milk products (g)</td><td align="center">16 &#x000b1; 32</td><td align="center">183 &#x000b1; 123</td><td align="left">0.0002</td></tr><tr><td align="left">Oil (g)</td><td align="center">0.3 &#x000b1; 0.7</td><td align="center">1.4 &#x000b1; 3.5</td><td align="left">0.3</td></tr><tr><td align="left">Sauce (g)</td><td align="center">13 &#x000b1; 20</td><td align="center">30 &#x000b1; 36</td><td align="left">0.2</td></tr><tr><td align="left">Bakery (g)</td><td align="center">10 &#x000b1; 18</td><td align="center">34 &#x000b1; 35</td><td align="left">0.005</td></tr><tr><td align="left">Jam (g)</td><td align="center">0 &#x000b1; 0</td><td align="center">12 &#x000b1; 22</td><td align="left">0.07</td></tr><tr><td align="left">Spirits (g)</td><td align="center">1.0 &#x000b1; 2.8</td><td align="center">1.4 &#x000b1; 4.1</td><td align="left">0.8</td></tr><tr><td align="left">Wine (g)</td><td align="center">52 &#x000b1; 83</td><td align="center">20 &#x000b1; 49</td><td align="left">0.14</td></tr><tr><td align="left">Beer (g)</td><td align="center">31 &#x000b1; 103</td><td align="center">55 &#x000b1; 80</td><td align="left">0.4</td></tr><tr><td align="left">Sweet beverages (g)</td><td align="center">0 &#x000b1; 0</td><td align="center">38 &#x000b1; 64</td><td align="left">0.051</td></tr><tr><td align="left">Juice (g)</td><td align="center">12 &#x000b1; 35</td><td align="center">10 &#x000b1; 26</td><td align="left">0.6</td></tr></tbody></table><table-wrap-foot><p>Average food eaten per day during Paleolithic diet and Diabetes diet (mean &#x000b1; SD). Estimated from 4 day weighed food records. *P for difference between diets in a two-sided t-test with dependent samples. E% = percent energy from total macronutrient energy.</p></table-wrap-foot></table-wrap></sec><sec><title>Exploratory analyses</title><p>In exploratory analyses of primary endpoints, within-subject differences (&#x00394;) in HbA1c (&#x00394;HbA1c) correlated with &#x00394;waist circumference, which correlated with &#x00394;weight, which correlated with &#x00394;CRP (Table <xref ref-type="table" rid="T6">6</xref>). Furthermore, &#x00394;HDL correlated with &#x00394;cholesterol and &#x00394;DBP with &#x00394;HOMA2 IR (Table <xref ref-type="table" rid="T6">6</xref>). In exploratory analyses of estimated intake of nutrients, &#x00394;HbA1c correlated with &#x00394;potassium, &#x00394;HDL with &#x00394;fatty acid C20:5 n-3, &#x00394;TG with &#x00394;thiamin, &#x00394;DBP with &#x00394;dietary cholesterol, &#x00394;weight with &#x00394;energy density per meal, and &#x00394;waist circumference with &#x00394;bakery, &#x00394;energy density per meal, &#x00394;sauce and &#x00394;vitamin E (Table <xref ref-type="table" rid="T6">6</xref>).</p><table-wrap position="float" id="T6"><label>Table 6</label><caption><p>Exploratory analyses</p></caption><table frame="hsides" rules="groups"><thead><tr><td></td><td align="left">Bivariate correlation P*</td><td align="left">Pearson correlation r</td><td align="left">Linear regression P<sup>&#x000a7;</sup></td><td align="left">Adjusted R<sup>2</sup></td></tr></thead><tbody><tr><td align="left">&#x00394;HbA1C versus outcome variables</td><td></td><td></td><td></td><td></td></tr><tr><td align="left">&#x02003;&#x00394;Waist circumference (cm)</td><td align="left">0.03</td><td align="left">0.6</td><td align="left">0.03</td><td align="left">0.31</td></tr><tr><td align="left">&#x00394;HbA1C versus dietary variables</td><td></td><td></td><td></td><td></td></tr><tr><td align="left">&#x02003;&#x00394;Potassium (mg)</td><td align="left">0.03</td><td align="left">0.6</td><td align="left">0.03</td><td align="left">0.32</td></tr><tr><td align="left">&#x02003;&#x00394;Fruits (g)</td><td align="left">0.04</td><td align="left">0.6</td><td align="left">NS</td><td></td></tr><tr><td align="left">&#x02003;&#x00394;Sauce (g)</td><td align="left">0.04</td><td align="left">-0.6</td><td align="left">NS</td><td></td></tr><tr><td align="left">&#x02003;&#x00394;Milk/milk products (g)</td><td align="left">0.05</td><td align="left">0.6</td><td align="left">NS</td><td></td></tr><tr><td align="left">&#x00394;HDL versus outcome variables</td><td></td><td></td><td></td><td></td></tr><tr><td align="left">&#x02003;&#x00394;Cholesterol (mmol/l)</td><td align="left">0.03</td><td align="left">0.6</td><td align="left">0.03</td><td align="left">0.32</td></tr><tr><td align="left">&#x00394;HDL versus dietary variables</td><td></td><td></td><td></td><td></td></tr><tr><td align="left">&#x02003;&#x00394;Fatty acid C20:5, n-3, EPA (g)</td><td align="left">0.004</td><td align="left">-0.7</td><td align="left">0.004</td><td align="left">0.51</td></tr><tr><td align="left">&#x02003;&#x00394;Vitamin C, Ascorbic acid (mg)</td><td align="left">0.02</td><td align="left">-0.6</td><td align="left">NS</td><td></td></tr><tr><td></td><td></td><td></td><td></td><td></td></tr><tr><td align="left">&#x00394;TG versus outcome variables</td><td></td><td></td><td></td><td></td></tr><tr><td align="left">&#x02003;No correlations</td><td></td><td></td><td></td><td></td></tr><tr><td align="left">&#x00394;TG versus dietary variables</td><td></td><td></td><td></td><td></td></tr><tr><td align="left">&#x02003;&#x00394;Vitamin B-1, Thiamin (mg)</td><td align="left">0.03</td><td align="left">0.6</td><td align="left">0.03</td><td align="left">0.29</td></tr><tr><td></td><td></td><td></td><td></td><td></td></tr><tr><td align="left">&#x00394;DBP versus outcome variables</td><td></td><td></td><td></td><td></td></tr><tr><td align="left">&#x02003;&#x00394;HOMA2 IR</td><td align="left">0.004</td><td align="left">-0.7</td><td align="left">0.01</td><td align="left">0.67</td></tr><tr><td align="left">&#x02003;&#x00394;SBP (mmHg)</td><td align="left">0.03</td><td align="left">0.6</td><td align="left">0.03</td><td></td></tr><tr><td align="left">&#x02003;&#x00394;fP-insulin (pmol/l)</td><td align="left">0.004</td><td align="left">-0.7</td><td align="left">NS</td><td></td></tr><tr><td align="left">&#x02003;&#x00394;HOMA2 %S</td><td align="left">0.01</td><td align="left">0.7</td><td align="left">NS</td><td></td></tr><tr><td align="left">&#x02003;&#x00394;AUC insulin<sub>0&#x02013;120 </sub>(nmol/l&#x000b7;min)</td><td align="left">0.01</td><td align="left">-0.7</td><td align="left">NS</td><td></td></tr><tr><td align="left">&#x00394;DBP versus dietary variables</td><td></td><td></td><td></td><td></td></tr><tr><td align="left">&#x02003;&#x00394;Dietary cholesterol (mg)</td><td align="left">0.001</td><td align="left">0.8</td><td align="left">0.001</td><td align="left">0.60</td></tr><tr><td align="left">&#x02003;&#x00394;Fatty acid C16:1 (g)</td><td align="left">0.002</td><td align="left">0.8</td><td align="left">NS</td><td></td></tr><tr><td align="left">&#x02003;&#x00394;Fatty acid C22:6, n-3, DHA (g)</td><td align="left">0.01</td><td align="left">0.7</td><td align="left">NS</td><td></td></tr><tr><td align="left">&#x02003;&#x00394;Fatty acid C20:5, n-3, EPA (g)</td><td align="left">0.02</td><td align="left">0.6</td><td align="left">NS</td><td></td></tr><tr><td align="left">&#x02003;&#x00394;Eggs (g)</td><td align="left">0.03</td><td align="left">0.6</td><td align="left">NS</td><td></td></tr><tr><td></td><td></td><td></td><td></td><td></td></tr><tr><td align="left">&#x00394;Weight versus outcome variables</td><td></td><td></td><td></td><td></td></tr><tr><td align="left">&#x02003;&#x00394;CRP (mg/l)</td><td align="left">0.000005</td><td align="left">0.9</td><td align="left">0.001</td><td align="left">0.85</td></tr><tr><td align="left">&#x02003;&#x00394;BMI (kg/m<sup>2</sup>)</td><td align="left">0.00002</td><td align="left">0.9</td><td align="left">NE</td><td></td></tr><tr><td align="left">&#x02003;&#x00394;Waist circumference (cm)</td><td align="left">0.0001</td><td align="left">0.9</td><td align="left">NS</td><td></td></tr><tr><td align="left">&#x02003;&#x00394;ISI<sub>0,120 </sub>(mg&#x000b7;l<sup>2</sup>/mmol&#x000b7;mU&#x000b7;min)</td><td align="left">0.001</td><td align="left">-0.8</td><td align="left">NS</td><td></td></tr><tr><td align="left">&#x00394;Weight versus dietary variables</td><td></td><td></td><td></td><td></td></tr><tr><td align="left">&#x02003;&#x00394;Energy density per meal (kJ/g)</td><td align="left">0.00003</td><td align="left">-0.9</td><td align="left">0.00003</td><td align="left">0.79</td></tr><tr><td align="left">&#x02003;&#x00394;Vitamin E (mg)</td><td align="left">0.01</td><td align="left">-0.7</td><td align="left">NS</td><td></td></tr><tr><td align="left">&#x02003;&#x00394;Vegetables (g)</td><td align="left">0.01</td><td align="left">0.7</td><td align="left">NS</td><td></td></tr><tr><td align="left">&#x02003;&#x00394;Fatty acid C18:1 (g)</td><td align="left">0.02</td><td align="left">-0.6</td><td align="left">NS</td><td></td></tr><tr><td></td><td></td><td></td><td></td><td></td></tr><tr><td align="left">&#x00394;BMI versus outcome variables</td><td></td><td></td><td></td><td></td></tr><tr><td align="left">&#x02003;&#x00394;Weight (kg)</td><td align="left">0.00002</td><td align="left">0.9</td><td align="left">NE</td><td></td></tr><tr><td align="left">&#x02003;&#x00394;Waist circumference (cm)</td><td align="left">0.001</td><td align="left">0.8</td><td align="left">0.001</td><td align="left">0.63</td></tr><tr><td align="left">&#x02003;&#x00394;CRP (mg/l)</td><td align="left">0.001</td><td align="left">0.8</td><td align="left">NS</td><td></td></tr><tr><td align="left">&#x02003;&#x00394;ISI<sub>0,120 </sub>(mg&#x000b7;l<sup>2</sup>/mmol&#x000b7;mU&#x000b7;min)</td><td align="left">0.003</td><td align="left">-0.8</td><td align="left">NS</td><td></td></tr><tr><td align="left">&#x00394;BMI versus dietary variables</td><td></td><td></td><td></td><td></td></tr><tr><td align="left">&#x02003;&#x00394;Energy density per meal (kJ/g)</td><td align="left">0.0004</td><td align="left">-0.8</td><td align="left">0.0004</td><td align="left">0.67</td></tr><tr><td align="left">&#x02003;&#x00394;Vitamin E (mg)</td><td align="left">0.004</td><td align="left">-0.7</td><td align="left">NS</td><td></td></tr><tr><td align="left">&#x02003;&#x00394;Vegetables (g)</td><td align="left">0.01</td><td align="left">0.7</td><td align="left">NS</td><td></td></tr><tr><td align="left">&#x02003;&#x00394;Fatty acid C18:1 (g)</td><td align="left">0.01</td><td align="left">-0.7</td><td align="left">NS</td><td></td></tr><tr><td align="left">&#x02003;&#x00394;Fat (g)</td><td align="left">0.02</td><td align="left">-0.6</td><td align="left">NS</td><td></td></tr><tr><td align="left">&#x02003;&#x00394;Fatty acid C18:2, n-6, Linoleic acid (g)</td><td align="left">0.047</td><td align="left">-0.6</td><td align="left">NS</td><td></td></tr><tr><td></td><td></td><td></td><td></td><td></td></tr><tr><td align="left">&#x00394;Waist circumference versus outcome variables</td><td></td><td></td><td></td><td></td></tr><tr><td align="left">&#x02003;&#x00394;Weight (kg)</td><td align="left">0.0001</td><td align="left">0.9</td><td align="left">0.0001</td><td align="left">0.74</td></tr><tr><td align="left">&#x02003;&#x00394;BMI (kg/m<sup>2</sup>)</td><td align="left">0.001</td><td align="left">0.8</td><td align="left">NS</td><td></td></tr><tr><td align="left">&#x02003;&#x00394;CRP (mg/l)</td><td align="left">0.001</td><td align="left">0.8</td><td align="left">NS</td><td></td></tr><tr><td align="left">&#x02003;&#x00394;ISI<sub>0,120 </sub>(mg&#x000b7;l<sup>2</sup>/mmol&#x000b7;mU&#x000b7;min)</td><td align="left">0.002</td><td align="left">-0.8</td><td align="left">NS</td><td></td></tr><tr><td align="left">&#x02003;&#x00394;HbA1C (%)</td><td align="left">0.03</td><td align="left">0.6</td><td align="left">NS</td><td></td></tr><tr><td></td><td></td><td></td><td></td><td></td></tr><tr><td align="left">&#x00394;Waist circumference versus dietary variables</td><td></td><td></td><td></td><td></td></tr><tr><td align="left">&#x02003;&#x00394;Bakery (g)</td><td align="left">0.01</td><td align="left">-0.7</td><td align="left">0.006</td><td align="left">0.92</td></tr><tr><td align="left">&#x02003;&#x00394;Energy density per meal (kJ/g)</td><td align="left">0.001</td><td align="left">-0.8</td><td align="left">0.007</td><td></td></tr><tr><td align="left">&#x02003;&#x00394;Sauce (g)</td><td align="left">0.02</td><td align="left">-0.6</td><td align="left">0.009</td><td></td></tr><tr><td align="left">&#x02003;&#x00394;Vitamin E (mg)</td><td align="left">0.003</td><td align="left">-0.7</td><td align="left">0.03</td><td></td></tr><tr><td align="left">&#x02003;&#x00394;Fatty acid C18:1 (g)</td><td align="left">0.01</td><td align="left">-0.7</td><td align="left">NS</td><td></td></tr><tr><td align="left">&#x02003;&#x00394;Vitamin E, Alpha-tocopherol (mg)</td><td align="left">0.04</td><td align="left">-0.6</td><td align="left">NS</td><td></td></tr></tbody></table><table-wrap-foot><p>Exploratory analyses performed on outcome variables with significant effects from Paleolithic diet compared to Diabetes diet. Analyses consisted of bivariate correlations between within-subject differences (&#x00394;) in outcome and dietary variables. Significantly correlating variables were entered into a stepwise forward linear regression analyses. *P for bivariate correlation between variables in a two-sided t-test. &#x000a7;P for stepwise forward linear regression analyses entering significantly correlated variables. NS = Not Significant. NE = Weight and BMI not entered in their respective regression analysis due to calculatory relatedness.</p></table-wrap-foot></table-wrap></sec></sec><sec><title>Discussion</title><sec><title>Key findings</title><p>The advice for patients with type 2 diabetes to follow a Paleolithic diet resulted in lower HbA1c, TG, DBP, weight and waist circumference, and higher HDL, as compared to a Diabetes diet according to current guidelines. In addition, fasting glucose and SBP tended to decrease more after the Paleolithic diet. Changes in glucose tolerance were not significantly different between diets. The two diets differed mainly in that the Paleolithic diet was lower in cereals and dairy products, and higher in fruits, vegetables, meat and eggs. Further, the Paleolithic diet was lower in total energy, energy density, carbohydrate, dietary GL, saturated fatty acids and calcium, and higher in unsaturated fatty acids, dietary cholesterol and several vitamins. Dietary GI was lower in the Paleolithic diet (GI = 50) than in the Diabetic diet (GI = 55).</p></sec><sec><title>Possible mechanisms and explanations</title><p>No advice was given to restrict food intake. Therefore, the lower reported energy intake during the Paleolithic diet despite no difference in weight of reported food intake agrees with the notion that such a diet is satiating and facilitates a reduced caloric intake [<xref ref-type="bibr" rid="B4">4</xref>,<xref ref-type="bibr" rid="B27">27</xref>]. Accordingly, energy density was lower in the Paleolithic diet and also correlated with alterations of both weight and waist circumference. The higher amount of fruit and vegetables during the Paleolithic period may have promoted weight loss due to its high content of water, which is thought to be satiating [<xref ref-type="bibr" rid="B28">28</xref>]. Interestingly, the Paleolithic diet appeared to be satiating despite a lower content of fiber in this study. The slightly higher relative protein intake, as percentage of total calorie intake, may also have added to a satiating effect [<xref ref-type="bibr" rid="B29">29</xref>,<xref ref-type="bibr" rid="B30">30</xref>]. Alternative explanations on satiation, such as dietary effects on leptin resistance, could also be considered [<xref ref-type="bibr" rid="B31">31</xref>].</p><p>A reduced energy intake would evidently be a major explanation for the beneficial effects of the Paleolithic diet on weight and waist circumference. Meta-analyses and large trials with various lifestyle interventions indicate that reduced caloric intake is more important for long-term weight loss than other known dietary factors, including macronutrient composition [<xref ref-type="bibr" rid="B32">32</xref>-<xref ref-type="bibr" rid="B40">40</xref>]. In studies shorter than 6 months, such as this one, differences in GI and/or GL may also have played a role for weight change. A Cochrane review found that overweight or obese people lost slightly more weight during 5&#x02013;12 weeks of low GI diets [<xref ref-type="bibr" rid="B41">41</xref>], and short-term carbohydrate restriction possibly results in greater weight loss than low-fat diets [<xref ref-type="bibr" rid="B29">29</xref>]. However, dietary GI and dietary GL did not correlate with alterations of weight, waist circumference or metabolic variables in our study. It should also be noted that, in the present study, reported mean absolute carbohydrate intake in the Paleolithic diet (g per day) was only slightly below the 130 g per day recommended by the American Diabetes Association, and clearly above 50 g per day, which has been proposed as the level below which a diet should be termed a low carbohydrate diet [<xref ref-type="bibr" rid="B42">42</xref>].</p><p>Paleolithic diet improved the glycemic control in the subjects, as evident by the reduction of HbA1c levels by -0.4 percentage points lower as compared to the diabetes diet. Since both glucose and insulin levels declined during Paleolithic diet, a main mechanism behind the improved glycemic control is probably improved insulin sensitivity, which may have allowed the released insulin to work more efficiently. The difference in reduction in HbA1c of 0.4% units between the Paleolithic and Diabetes diet is close to the average 0.5% units in a recent Cochrane review of diets with a low glycemic index or glycemic load [<xref ref-type="bibr" rid="B8">8</xref>]. However, the differences in GI between diets in that meta-analysis were considerably larger than in our trial. Glucose tolerance, which also determines the glucose response and thereby HbA1c, did not improve more during the Paleolithic diet. This result agrees with findings from Frassetto et al [<xref ref-type="bibr" rid="B10">10</xref>], but differs from our previous parallel-group trial which compared a Paleolithic diet with a Mediterranean-like diet in subjects with diabetes or impaired glucose tolerance [<xref ref-type="bibr" rid="B4">4</xref>]. Glucose tolerance has not been shown to improve after reduced carbohydrate intake in earlier dietary studies [<xref ref-type="bibr" rid="B43">43</xref>-<xref ref-type="bibr" rid="B46">46</xref>].</p><p>The much higher fruit intake of the Paleolithic diet probably resulted in a slightly higher intake of fructose which may have aided in the reduction of HbA1c. Fructose in exchange for starch, sucrose or glucose decreases postprandial glycemia [<xref ref-type="bibr" rid="B47">47</xref>], while the effect on glucose tolerance and insulin sensitivity is more uncertain [<xref ref-type="bibr" rid="B48">48</xref>]. The effect of fruit on TG and other risk factors is expected to have been neutral in this study [<xref ref-type="bibr" rid="B48">48</xref>,<xref ref-type="bibr" rid="B49">49</xref>]. Total intake of monosaccharides was 46 g per day, including approximately equal amounts of glucose and fructose, which was well below the suggested safety limit of 50 g fructose per day [<xref ref-type="bibr" rid="B48">48</xref>]. Our study lends further support to the notion that fruit intake should not be restricted in patients with type 2 diabetes.</p><p>The lower DBP after the Paleolithic diet compared to the Diabetes diet did not correlate with sodium intake, which did not differ significantly and was rather low in both diets (2.5 g and 3.0 g per day respectively for the Paleolithic and Diabetes diet).</p><p>The reduction of TG after the Paleolithic diet was possibly due to greater loss of abdominal fat [<xref ref-type="bibr" rid="B50">50</xref>] or lower GL compared to the Diabetes diet [<xref ref-type="bibr" rid="B6">6</xref>], although no correlation of TG with waist loss or GL was seen in exploratory analyses. A small additional effect on TG may be attributable to a trend for higher content of long-chain omega-3 fatty acids in the Paleolithic diet, while the higher dietary cholesterol content of the Paleolithic diet is probably of minor significance [<xref ref-type="bibr" rid="B51">51</xref>].</p></sec><sec><title>Comparison with findings from other studies</title><p>All improvements in markers of the metabolic syndrome on the Paleolithic diet are in line with findings from epidemiological studies in non-Western populations [<xref ref-type="bibr" rid="B14">14</xref>-<xref ref-type="bibr" rid="B16">16</xref>]. Improvements in HbA1c [<xref ref-type="bibr" rid="B4">4</xref>], weight [<xref ref-type="bibr" rid="B4">4</xref>,<xref ref-type="bibr" rid="B12">12</xref>,<xref ref-type="bibr" rid="B52">52</xref>], BMI [<xref ref-type="bibr" rid="B52">52</xref>], waist circumference [<xref ref-type="bibr" rid="B4">4</xref>,<xref ref-type="bibr" rid="B52">52</xref>], DBP [<xref ref-type="bibr" rid="B10">10</xref>], and TG [<xref ref-type="bibr" rid="B10">10</xref>], compared to baseline, on a Paleolithic diet have been observed before in intervention studies, while improvements in HDL have not. Similar differences in weight and DBP on a Paleolithic diet, compared to a cereal based diet, have been observed before in an intervention study on domestic pigs [<xref ref-type="bibr" rid="B11">11</xref>]. A lower reported energy intake and energy density of food despite food intake ad libitum agrees with our earlier findings that a Paleolithic diet facilitates a reduction of caloric intake [<xref ref-type="bibr" rid="B4">4</xref>,<xref ref-type="bibr" rid="B11">11</xref>,<xref ref-type="bibr" rid="B27">27</xref>].</p><p>Also, lower intake of cereals, dairy products, carbohydrates, dietary GL and saturated fat, and higher intake of fruit and potassium have been observed before [<xref ref-type="bibr" rid="B4">4</xref>,<xref ref-type="bibr" rid="B10">10</xref>]. Lower intake of potatoes, bakery, fiber, phosphorous and calcium, and higher intake in vegetables, meat, eggs, monosaccharides, dietary cholesterol, vitamin B6, vitamin C, niacin and selenium have not been observed before in intervention studies with a Paleolithic diet. Dietary GI for a Paleolithic diet has not been determined before.</p></sec><sec><title>Limitations of the present study</title><p>A limitation of this study, as with most other dietary trials, is the lack of blinding after randomization. To minimize this problem, all study participants were informed of the intention to compare two healthy diets in the treatment of type 2 diabetes and that it was unknown if any of them would be superior to the other. Also, written information with dietary advice and food recipes were similarly formulated for both diets. Furthermore, for increased conformity, the dietary advice and data collection procedure were discussed by all those administering the interventions at several meetings prior to start of study.</p><p>Another limitation of this study is its small size which did not reach the number of participants needed as calculated in the pre-study power calculation. The decision to end the study was taken when recruitment for the study had not yielded new participants for more than six months. The population of patients with type 2 diabetes is much larger and therapy continues for substantially longer than in this study. Moreover, many patients with type 2 diabetes have illnesses and treatments that excluded them from the current study. Consequently, the results of this study do not address the occurrence of rare adverse events, nor can they be extrapolated to all patients seen in general clinical practice.</p><p>The carry-over effects on HbA1c were not due to carry-over or period effects in reported food intake. Instead, they could be true carry-over effects of the first diet. This is particularly likely for HbA1c, since HbA1c represents a weighted average of the blood glucose concentration over the previous two to three months ([<xref ref-type="bibr" rid="B53">53</xref>]. If results from the second period were discarded (owing to carryover [<xref ref-type="bibr" rid="B54">54</xref>]), the reduction of HbA1c from the Paleolithic diet compared to the Diabetes diet was still significant (<italic>p </italic>= 0.01) and even larger (-1.3% units) than when results from the second period were included. However, this approach could lead to biased answers to our hypothesis and results from both periods are therefore used in this study [<xref ref-type="bibr" rid="B54">54</xref>].</p><p>The lack of carry-over or period effects in reported food intake indicates fairly good adherence to intervention diets. Reported food intake in this study seemed reasonable both in distribution and quantity, as subjectively assessed by a nutrition engineer skilled in analyzing reported food intake (YG). Furthermore, the reported lower energy intake of 1.3 MJ per day on a Paleolithic diet equals about 3.2 kg fat during three months, which almost exactly accounts for the observed 3.3 kg difference in weight loss between diets. This indicates both good reporting by the participants and good adherence to reported food intake during the study.</p></sec><sec><title>Clinical and research implications</title><p>The favourable results in this study are in line with previous findings and increase the generalizability of the Paleolithic diet by testing it in both men and women in a primary care setting. A limitation of the study is the small size of the study population. This prevents the conclusions from resulting in nutritional recommendations for patients with type 2 diabetes. A long-term study in a larger population is therefore required. In parallel, further research into possible mechanisms for the beneficial effects of a Paleolithic diet should be done.</p><p>Total protein intake in g per day did not differ between the diets, but, as a result of the difference in total energy intake, the energy percentage (E%) from dietary protein on the Paleolithic diet (24 E%) slightly exceeded US and European recommendations for people with diabetes (&#x0003c;20 E%) [<xref ref-type="bibr" rid="B17">17</xref>,<xref ref-type="bibr" rid="B55">55</xref>]. The debatable disadvantage for long-term kidney function [<xref ref-type="bibr" rid="B56">56</xref>,<xref ref-type="bibr" rid="B57">57</xref>] should be weighed against the benefits of attenuated postprandial glycemia when protein replaces starch or glucose [<xref ref-type="bibr" rid="B58">58</xref>].</p><p>Calcium intake did not meet recommendations for any of the diets, and it was particularly low in the Paleolithic diet. Recent calcium balance studies indicate that human calcium requirements are lower than previously thought [<xref ref-type="bibr" rid="B59">59</xref>], and meta-analyses of randomized controlled trials suggest that the effect of calcium supplementation for bone strength is limited [<xref ref-type="bibr" rid="B60">60</xref>,<xref ref-type="bibr" rid="B61">61</xref>]. It has been suggested that absorption and excretion of calcium are more important than calcium intake for whole-body calcium balance [<xref ref-type="bibr" rid="B62">62</xref>]. In this context, the lower content of calcium-binding phytate and the lower dietary acid load from a Paleolithic diet may hypothetically compensate for the low amount of calcium [<xref ref-type="bibr" rid="B63">63</xref>]. Supporting this view are the findings of Frassetto et al, where calcium intake remained unchanged and urine calcium decreased after a Paleolithic diet compared to baseline [<xref ref-type="bibr" rid="B10">10</xref>].</p><p>As has been discussed, there may be a challenge to implement and adopt the Paleolithic diet on a worldwide scale in subjects with type 2 diabetes. However, this aspect is beyond the objective of this paper and requires more research.</p></sec></sec><sec><title>Conclusion</title><p>Based on the results of this 3-month randomized cross-over study in subjects with type 2 diabetes, a Paleolithic diet improves glycemic control in association with improvement of several cardiovascular risk factors compared to a conventional diabetes diet. The study supports the initiation of a large scale study on the effect of Paleolithic diet in subjects with type 2 diabetes.</p></sec><sec><title>Competing interests</title><p>The authors declare that they have no competing interests.</p></sec><sec><title>Authors' contributions</title><p>TJ participated in the design and execution of the study, participated in statistical analysis, and conceived of and wrote the article. YG analyzed reported food intake and participated in the design of the article as well as revising it for important intellectual content. BA participated in the design of the study, carried out the analysis of glucose and insulin in OGTTs, and revised the article for important intellectual content. UCB, GP, AH and MS participated in the design and execution of the study, and revised the article for important intellectual content. SL participated in the design of the study, participated in statistical analysis, and participated in the design of the article as well as revising it for important intellectual content. All authors read and approved the final manuscript.</p></sec></body><back><ack><sec><title>Acknowledgements</title><p>The authors are grateful to professor Birgitta Hov&#x000e9;lius and Dr Kristina Haara for participation in designing the study, and to Lilian Bengtsson and Lena Kvist for technical assistance. The study was funded by Crafoordska stiftelsen, Region Sk&#x000e5;ne and Lund University.</p></sec></ack><ref-list><ref id="B1"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nield</surname><given-names>L</given-names></name><name><surname>Moore</surname><given-names>HJ</given-names></name><name><surname>Hooper</surname><given-names>L</given-names></name><name><surname>Cruickshank</surname><given-names>JK</given-names></name><name><surname>Vyas</surname><given-names>A</given-names></name><name><surname>Whittaker</surname><given-names>V</given-names></name><name><surname>Summerbell</surname><given-names>CD</given-names></name></person-group><article-title>Dietary advice for treatment of type 2 diabetes mellitus in adults</article-title><source>Cochrane Database Syst Rev</source><year>2007</year><fpage>CD004097</fpage><pub-id pub-id-type="pmid">17636747</pub-id></citation></ref><ref id="B2"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Eaton</surname><given-names>S</given-names></name><name><surname>Konner</surname><given-names>M</given-names></name></person-group><article-title>Paleolithic nutrition. A consideration of its nature and current implications</article-title><source>N Engl J Med</source><year>1985</year><volume>312</volume><fpage>283</fpage><lpage>289</lpage><pub-id pub-id-type="pmid">2981409</pub-id></citation></ref><ref id="B3"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lindeberg</surname><given-names>S</given-names></name><name><surname>Cordain</surname><given-names>L</given-names></name><name><surname>Eaton</surname><given-names>SB</given-names></name></person-group><article-title>Biological and clinical potential of a palaeolithic diet</article-title><source>J Nutr Environ Med</source><year>2003</year><volume>13</volume><fpage>1</fpage><lpage>12</lpage><pub-id pub-id-type="doi">10.1080/13590840310001619397</pub-id></citation></ref><ref id="B4"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lindeberg</surname><given-names>S</given-names></name><name><surname>Jonsson</surname><given-names>T</given-names></name><name><surname>Granfeldt</surname><given-names>Y</given-names></name><name><surname>Borgstrand</surname><given-names>E</given-names></name><name><surname>Soffman</surname><given-names>J</given-names></name><name><surname>Sjostrom</surname><given-names>K</given-names></name><name><surname>Ahren</surname><given-names>B</given-names></name></person-group><article-title>A Palaeolithic diet improves glucose tolerance more than a Mediterranean-like diet in individuals with ischaemic heart disease</article-title><source>Diabetologia</source><year>2007</year><volume>50</volume><fpage>1795</fpage><lpage>1807</lpage><pub-id pub-id-type="pmid">17583796</pub-id><pub-id pub-id-type="doi">10.1007/s00125-007-0716-y</pub-id></citation></ref><ref id="B5"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Howlett</surname><given-names>J</given-names></name><name><surname>Ashwell</surname><given-names>M</given-names></name></person-group><article-title>Glycemic response and health: summary of a workshop</article-title><source>Am J Clin Nutr</source><year>2008</year><volume>87</volume><fpage>212S</fpage><lpage>216S</lpage><pub-id pub-id-type="pmid">18175760</pub-id></citation></ref><ref id="B6"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Livesey</surname><given-names>G</given-names></name><name><surname>Taylor</surname><given-names>R</given-names></name><name><surname>Hulshof</surname><given-names>T</given-names></name><name><surname>Howlett</surname><given-names>J</given-names></name></person-group><article-title>Glycemic response and health &#x02013; a systematic review and meta-analysis: relations between dietary glycemic properties and health outcomes</article-title><source>Am J Clin Nutr</source><year>2008</year><volume>87</volume><fpage>258S</fpage><lpage>268S</lpage><pub-id pub-id-type="pmid">18175766</pub-id></citation></ref><ref id="B7"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Riccardi</surname><given-names>G</given-names></name><name><surname>Rivellese</surname><given-names>AA</given-names></name><name><surname>Giacco</surname><given-names>R</given-names></name></person-group><article-title>Role of glycemic index and glycemic load in the healthy state, in prediabetes, and in diabetes</article-title><source>Am J Clin Nutr</source><year>2008</year><volume>87</volume><fpage>269S</fpage><lpage>274S</lpage><pub-id pub-id-type="pmid">18175767</pub-id></citation></ref><ref id="B8"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Thomas</surname><given-names>D</given-names></name><name><surname>Elliott</surname><given-names>EJ</given-names></name></person-group><article-title>Low glycaemic index, or low glycaemic load, diets for diabetes mellitus</article-title><source>Cochrane Database Syst Rev</source><year>2009</year><fpage>CD006296</fpage><pub-id pub-id-type="pmid">19160276</pub-id></citation></ref><ref id="B9"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Osterdahl</surname><given-names>M</given-names></name><name><surname>Kocturk</surname><given-names>T</given-names></name><name><surname>Koochek</surname><given-names>A</given-names></name><name><surname>Wandell</surname><given-names>PE</given-names></name></person-group><article-title>Effects of a short-term intervention with a paleolithic diet in healthy volunteers</article-title><source>Eur J Clin Nutr</source><year>2008</year><volume>62</volume><fpage>682</fpage><lpage>685</lpage><pub-id pub-id-type="pmid">17522610</pub-id><pub-id pub-id-type="doi">10.1038/sj.ejcn.1602790</pub-id></citation></ref><ref id="B10"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Frassetto</surname><given-names>LA</given-names></name><name><surname>Schloetter</surname><given-names>M</given-names></name><name><surname>Mietus-Synder</surname><given-names>M</given-names></name><name><surname>Morris</surname><given-names>RC</given-names><suffix>Jr</suffix></name><name><surname>Sebastian</surname><given-names>A</given-names></name></person-group><article-title>Metabolic and physiologic improvements from consuming a paleolithic, hunter-gatherer type diet</article-title><source>Eur J Clin Nutr</source><year>2009</year><pub-id pub-id-type="pmid">19209185</pub-id></citation></ref><ref id="B11"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jonsson</surname><given-names>T</given-names></name><name><surname>Ahren</surname><given-names>B</given-names></name><name><surname>Pacini</surname><given-names>G</given-names></name><name><surname>Sundler</surname><given-names>F</given-names></name><name><surname>Wierup</surname><given-names>N</given-names></name><name><surname>Steen</surname><given-names>S</given-names></name><name><surname>Sjoberg</surname><given-names>T</given-names></name><name><surname>Ugander</surname><given-names>M</given-names></name><name><surname>Frostegard</surname><given-names>J</given-names></name><name><surname>Goransson</surname><given-names>L</given-names></name><name><surname>Lindeberg</surname><given-names>S</given-names></name></person-group><article-title>A Paleolithic diet confers higher insulin sensitivity, lower C-reactive protein and lower blood pressure than a cereal-based diet in domestic pigs</article-title><source>Nutr Metab (Lond)</source><year>2006</year><volume>3</volume><fpage>39</fpage><pub-id pub-id-type="pmid">17081292</pub-id><pub-id pub-id-type="doi">10.1186/1743-7075-3-39</pub-id></citation></ref><ref id="B12"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>O'Dea</surname><given-names>K</given-names></name></person-group><article-title>Marked improvement in carbohydrate and lipid metabolism in diabetic Australian aborigines after temporary reversion to traditional lifestyle</article-title><source>Diabetes</source><year>1984</year><volume>33</volume><fpage>596</fpage><lpage>603</lpage><pub-id pub-id-type="pmid">6373464</pub-id><pub-id pub-id-type="doi">10.2337/diabetes.33.6.596</pub-id></citation></ref><ref id="B13"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>O'Dea</surname><given-names>K</given-names></name><name><surname>Spargo</surname><given-names>RM</given-names></name><name><surname>Akerman</surname><given-names>K</given-names></name></person-group><article-title>The effect of transition from traditional to urban life-style on the insulin secretory response in Australian Aborigines</article-title><source>Diabetes Care</source><year>1980</year><volume>3</volume><fpage>31</fpage><lpage>37</lpage><pub-id pub-id-type="pmid">6996966</pub-id><pub-id pub-id-type="doi">10.2337/diacare.3.1.31</pub-id></citation></ref><ref id="B14"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lindeberg</surname><given-names>S</given-names></name><name><surname>Lundh</surname><given-names>B</given-names></name></person-group><article-title>Apparent absence of stroke and ischaemic heart disease in a traditional Melanesian island: a clinical study in Kitava</article-title><source>J Intern Med</source><year>1993</year><volume>233</volume><fpage>269</fpage><lpage>275</lpage><pub-id pub-id-type="pmid">8450295</pub-id></citation></ref><ref id="B15"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lindeberg</surname><given-names>S</given-names></name><name><surname>Nilsson-Ehle</surname><given-names>P</given-names></name><name><surname>Ter&#x000e9;nt</surname><given-names>A</given-names></name><name><surname>Vessby</surname><given-names>B</given-names></name><name><surname>Scherst&#x000e9;n</surname><given-names>B</given-names></name></person-group><article-title>Cardiovascular risk factors in a Melanesian population apparently free from stroke and ischaemic heart disease &#x02013; the Kitava study</article-title><source>J Intern Med</source><year>1994</year><volume>236</volume><fpage>331</fpage><lpage>340</lpage><pub-id pub-id-type="pmid">8077891</pub-id></citation></ref><ref id="B16"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lindeberg</surname><given-names>S</given-names></name><name><surname>Eliasson</surname><given-names>M</given-names></name><name><surname>Lindahl</surname><given-names>B</given-names></name><name><surname>Ahr&#x000e9;n</surname><given-names>B</given-names></name></person-group><article-title>Low serum insulin in traditional Pacific Islanders &#x02013; the Kitava Study</article-title><source>Metabolism</source><year>1999</year><volume>48</volume><fpage>1216</fpage><lpage>1219</lpage><pub-id pub-id-type="pmid">10535381</pub-id><pub-id pub-id-type="doi">10.1016/S0026-0495(99)90258-5</pub-id></citation></ref><ref id="B17"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mann</surname><given-names>JI</given-names></name><name><surname>De Leeuw</surname><given-names>I</given-names></name><name><surname>Hermansen</surname><given-names>K</given-names></name><name><surname>Karamanos</surname><given-names>B</given-names></name><name><surname>Karlstrom</surname><given-names>B</given-names></name><name><surname>Katsilambros</surname><given-names>N</given-names></name><name><surname>Riccardi</surname><given-names>G</given-names></name><name><surname>Rivellese</surname><given-names>AA</given-names></name><name><surname>Rizkalla</surname><given-names>S</given-names></name><name><surname>Slama</surname><given-names>G</given-names></name><name><surname>Toeller</surname><given-names>M</given-names></name><name><surname>Uusitupa</surname><given-names>M</given-names></name><name><surname>Vessby</surname><given-names>B</given-names></name></person-group><article-title>Evidence-based nutritional approaches to the treatment and prevention of diabetes mellitus</article-title><source>Nutr Metab Cardiovasc Dis</source><year>2004</year><volume>14</volume><fpage>373</fpage><lpage>394</lpage><pub-id pub-id-type="pmid">15853122</pub-id><pub-id pub-id-type="doi">10.1016/S0939-4753(04)80028-0</pub-id></citation></ref><ref id="B18"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Camelon</surname><given-names>KM</given-names></name><name><surname>Hadell</surname><given-names>K</given-names></name><name><surname>Jamsen</surname><given-names>PT</given-names></name><name><surname>Ketonen</surname><given-names>KJ</given-names></name><name><surname>Kohtamaki</surname><given-names>HM</given-names></name><name><surname>Makimatilla</surname><given-names>S</given-names></name><name><surname>Tormala</surname><given-names>ML</given-names></name><name><surname>Valve</surname><given-names>RH</given-names></name></person-group><article-title>The Plate Model: a visual method of teaching meal planning. DAIS Project Group. Diabetes Atherosclerosis Intervention Study</article-title><source>J Am Diet Assoc</source><year>1998</year><volume>98</volume><fpage>1155</fpage><lpage>1158</lpage><pub-id pub-id-type="pmid">9787722</pub-id><pub-id pub-id-type="doi">10.1016/S0002-8223(98)00267-3</pub-id></citation></ref><ref id="B19"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Eaton</surname><given-names>SB</given-names></name><name><surname>Strassman</surname><given-names>BI</given-names></name><name><surname>Nesse</surname><given-names>RM</given-names></name><name><surname>Neel</surname><given-names>JV</given-names></name><name><surname>Ewald</surname><given-names>PW</given-names></name><name><surname>Williams</surname><given-names>GC</given-names></name><name><surname>Weder</surname><given-names>AB</given-names></name><name><surname>Eaton</surname><given-names>SB</given-names><suffix>3rd</suffix></name><name><surname>Lindeberg</surname><given-names>S</given-names></name><name><surname>Konner</surname><given-names>MJ</given-names></name><name><surname>Mysterud</surname><given-names>I</given-names></name><name><surname>Cordain</surname><given-names>L</given-names></name></person-group><article-title>Evolutionary health promotion</article-title><source>Prev Med</source><year>2002</year><volume>34</volume><fpage>109</fpage><lpage>118</lpage><pub-id pub-id-type="pmid">11817903</pub-id><pub-id pub-id-type="doi">10.1006/pmed.2001.0876</pub-id></citation></ref><ref id="B20"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wallace</surname><given-names>TM</given-names></name><name><surname>Levy</surname><given-names>JC</given-names></name><name><surname>Matthews</surname><given-names>DR</given-names></name></person-group><article-title>Use and abuse of HOMA modeling</article-title><source>Diabetes Care</source><year>2004</year><volume>27</volume><fpage>1487</fpage><lpage>1495</lpage><pub-id pub-id-type="pmid">15161807</pub-id><pub-id pub-id-type="doi">10.2337/diacare.27.6.1487</pub-id></citation></ref><ref id="B21"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gutt</surname><given-names>M</given-names></name><name><surname>Davis</surname><given-names>CL</given-names></name><name><surname>Spitzer</surname><given-names>SB</given-names></name><name><surname>Llabre</surname><given-names>MM</given-names></name><name><surname>Kumar</surname><given-names>M</given-names></name><name><surname>Czarnecki</surname><given-names>EM</given-names></name><name><surname>Schneiderman</surname><given-names>N</given-names></name><name><surname>Skyler</surname><given-names>JS</given-names></name><name><surname>Marks</surname><given-names>JB</given-names></name></person-group><article-title>Validation of the insulin sensitivity index (ISI(0,120)): comparison with other measures</article-title><source>Diabetes Res Clin Pract</source><year>2000</year><volume>47</volume><fpage>177</fpage><lpage>184</lpage><pub-id pub-id-type="pmid">10741566</pub-id><pub-id pub-id-type="doi">10.1016/S0168-8227(99)00116-3</pub-id></citation></ref><ref id="B22"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jenkins</surname><given-names>DJ</given-names></name><name><surname>Wolever</surname><given-names>TM</given-names></name><name><surname>Taylor</surname><given-names>RH</given-names></name><name><surname>Barker</surname><given-names>H</given-names></name><name><surname>Fielden</surname><given-names>H</given-names></name><name><surname>Baldwin</surname><given-names>JM</given-names></name><name><surname>Bowling</surname><given-names>AC</given-names></name><name><surname>Newman</surname><given-names>HC</given-names></name><name><surname>Jenkins</surname><given-names>AL</given-names></name><name><surname>Goff</surname><given-names>DV</given-names></name></person-group><article-title>Glycemic index of foods: a physiological basis for carbohydrate exchange</article-title><source>Am J Clin Nutr</source><year>1981</year><volume>34</volume><fpage>362</fpage><lpage>366</lpage><pub-id pub-id-type="pmid">6259925</pub-id></citation></ref><ref id="B23"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jenkins</surname><given-names>DJ</given-names></name><name><surname>Wolever</surname><given-names>TM</given-names></name><name><surname>Jenkins</surname><given-names>AL</given-names></name><name><surname>Josse</surname><given-names>RG</given-names></name><name><surname>Wong</surname><given-names>GS</given-names></name></person-group><article-title>The glycaemic response to carbohydrate foods</article-title><source>Lancet</source><year>1984</year><volume>2</volume><fpage>388</fpage><lpage>391</lpage><pub-id pub-id-type="pmid">6147465</pub-id><pub-id pub-id-type="doi">10.1016/S0140-6736(84)90554-3</pub-id></citation></ref><ref id="B24"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Salmeron</surname><given-names>J</given-names></name><name><surname>Manson</surname><given-names>JE</given-names></name><name><surname>Stampfer</surname><given-names>MJ</given-names></name><name><surname>Colditz</surname><given-names>GA</given-names></name><name><surname>Wing</surname><given-names>AL</given-names></name><name><surname>Willett</surname><given-names>WC</given-names></name></person-group><article-title>Dietary fiber, glycemic load, and risk of non-insulin-dependent diabetes mellitus in women</article-title><source>Jama</source><year>1997</year><volume>277</volume><fpage>472</fpage><lpage>477</lpage><pub-id pub-id-type="pmid">9020271</pub-id><pub-id pub-id-type="doi">10.1001/jama.277.6.472</pub-id></citation></ref><ref id="B25"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Foster-Powell</surname><given-names>K</given-names></name><name><surname>Holt</surname><given-names>SH</given-names></name><name><surname>Brand-Miller</surname><given-names>JC</given-names></name></person-group><article-title>International table of glycemic index and glycemic load values: 2002</article-title><source>Am J Clin Nutr</source><year>2002</year><volume>76</volume><fpage>5</fpage><lpage>56</lpage><pub-id pub-id-type="pmid">12081815</pub-id></citation></ref><ref id="B26"><citation citation-type="book"><person-group person-group-type="author"><name><surname>Altman</surname><given-names>DG</given-names></name></person-group><source>Practical statistics for medical research</source><year>1991</year><publisher-name>London: Chapman and Hall</publisher-name></citation></ref><ref id="B27"><citation citation-type="book"><person-group person-group-type="author"><name><surname>J&#x000f6;nsson</surname><given-names>T</given-names></name></person-group><article-title>Healthy Satiety Effects of Paleolithic diet on Satiety and Risk factors for Cardiovascular disease</article-title><source>PhD Thesis</source><year>2007</year><publisher-name>Lund: Lund University</publisher-name></citation></ref><ref id="B28"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Davy</surname><given-names>BM</given-names></name><name><surname>Dennis</surname><given-names>EA</given-names></name><name><surname>Dengo</surname><given-names>AL</given-names></name><name><surname>Wilson</surname><given-names>KL</given-names></name><name><surname>Davy</surname><given-names>KP</given-names></name></person-group><article-title>Water consumption reduces energy intake at a breakfast meal in obese older adults</article-title><source>J Am Diet Assoc</source><year>2008</year><volume>108</volume><fpage>1236</fpage><lpage>1239</lpage><pub-id pub-id-type="pmid">18589036</pub-id><pub-id pub-id-type="doi">10.1016/j.jada.2008.04.013</pub-id></citation></ref><ref id="B29"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Clifton</surname><given-names>PM</given-names></name></person-group><article-title>Dietary treatment for obesity</article-title><source>Nature clinical practice</source><year>2008</year><volume>5</volume><fpage>672</fpage><lpage>681</lpage><pub-id pub-id-type="pmid">18852729</pub-id><pub-id pub-id-type="doi">10.1038/ncpgasthep1283</pub-id></citation></ref><ref id="B30"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Beasley</surname><given-names>JM</given-names></name><name><surname>Ange</surname><given-names>BA</given-names></name><name><surname>Anderson</surname><given-names>CA</given-names></name><name><surname>Miller</surname><given-names>ER</given-names><suffix>3rd</suffix></name><name><surname>Erlinger</surname><given-names>TP</given-names></name><name><surname>Holbrook</surname><given-names>JT</given-names></name><name><surname>Sacks</surname><given-names>FM</given-names></name><name><surname>Appel</surname><given-names>LJ</given-names></name></person-group><article-title>Associations Between Macronutrient Intake and Self-reported Appetite and Fasting Levels of Appetite Hormones: Results From the Optimal Macronutrient Intake Trial to Prevent Heart Disease</article-title><source>Am J Epidemiol</source><year>2009</year><volume>169</volume><fpage>893</fpage><lpage>900</lpage><pub-id pub-id-type="pmid">19224977</pub-id><pub-id pub-id-type="doi">10.1093/aje/kwn415</pub-id></citation></ref><ref id="B31"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jonsson</surname><given-names>T</given-names></name><name><surname>Olsson</surname><given-names>S</given-names></name><name><surname>Ahren</surname><given-names>B</given-names></name><name><surname>Bog-Hansen</surname><given-names>TC</given-names></name><name><surname>Dole</surname><given-names>A</given-names></name><name><surname>Lindeberg</surname><given-names>S</given-names></name></person-group><article-title>Agrarian diet and diseases of affluence &#x02013; Do evolutionary novel dietary lectins cause leptin resistance?</article-title><source>BMC Endocr Disord</source><year>2005</year><volume>5</volume><fpage>10</fpage><pub-id pub-id-type="pmid">16336696</pub-id><pub-id pub-id-type="doi">10.1186/1472-6823-5-10</pub-id></citation></ref><ref id="B32"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shai</surname><given-names>I</given-names></name><name><surname>Schwarzfuchs</surname><given-names>D</given-names></name><name><surname>Henkin</surname><given-names>Y</given-names></name><name><surname>Shahar</surname><given-names>DR</given-names></name><name><surname>Witkow</surname><given-names>S</given-names></name><name><surname>Greenberg</surname><given-names>I</given-names></name><name><surname>Golan</surname><given-names>R</given-names></name><name><surname>Fraser</surname><given-names>D</given-names></name><name><surname>Bolotin</surname><given-names>A</given-names></name><name><surname>Vardi</surname><given-names>H</given-names></name><name><surname>Tangi-Rozental</surname><given-names>O</given-names></name><name><surname>Zuk-Ramot</surname><given-names>R</given-names></name><name><surname>Sarusi</surname><given-names>B</given-names></name><name><surname>Brickner</surname><given-names>D</given-names></name><name><surname>Schwartz</surname><given-names>Z</given-names></name><name><surname>Sheiner</surname><given-names>E</given-names></name><name><surname>Marko</surname><given-names>R</given-names></name><name><surname>Katorza</surname><given-names>E</given-names></name><name><surname>Thiery</surname><given-names>J</given-names></name><name><surname>Fiedler</surname><given-names>GM</given-names></name><name><surname>Bluher</surname><given-names>M</given-names></name><name><surname>Stumvoll</surname><given-names>M</given-names></name><name><surname>Stampfer</surname><given-names>MJ</given-names></name></person-group><article-title>Weight loss with a low-carbohydrate, Mediterranean, or low-fat diet</article-title><source>N Engl J Med</source><year>2008</year><volume>359</volume><fpage>229</fpage><lpage>241</lpage><pub-id pub-id-type="pmid">18635428</pub-id><pub-id pub-id-type="doi">10.1056/NEJMoa0708681</pub-id></citation></ref><ref id="B33"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Due</surname><given-names>A</given-names></name><name><surname>Larsen</surname><given-names>TM</given-names></name><name><surname>Mu</surname><given-names>H</given-names></name><name><surname>Hermansen</surname><given-names>K</given-names></name><name><surname>Stender</surname><given-names>S</given-names></name><name><surname>Astrup</surname><given-names>A</given-names></name></person-group><article-title>Comparison of 3 ad libitum diets for weight-loss maintenance, risk of cardiovascular disease, and diabetes: a 6-mo randomized, controlled trial</article-title><source>Am J Clin Nutr</source><year>2008</year><volume>88</volume><fpage>1232</fpage><lpage>1241</lpage><pub-id pub-id-type="pmid">18996857</pub-id></citation></ref><ref id="B34"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gardner</surname><given-names>CD</given-names></name><name><surname>Kiazand</surname><given-names>A</given-names></name><name><surname>Alhassan</surname><given-names>S</given-names></name><name><surname>Kim</surname><given-names>S</given-names></name><name><surname>Stafford</surname><given-names>RS</given-names></name><name><surname>Balise</surname><given-names>RR</given-names></name><name><surname>Kraemer</surname><given-names>HC</given-names></name><name><surname>King</surname><given-names>AC</given-names></name></person-group><article-title>Comparison of the Atkins, Zone, Ornish, and LEARN diets for change in weight and related risk factors among overweight premenopausal women: the A TO Z Weight Loss Study: a randomized trial</article-title><source>Jama</source><year>2007</year><volume>297</volume><fpage>969</fpage><lpage>977</lpage><pub-id pub-id-type="pmid">17341711</pub-id><pub-id pub-id-type="doi">10.1001/jama.297.9.969</pub-id></citation></ref><ref id="B35"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jebb</surname><given-names>SA</given-names></name></person-group><article-title>Dietary determinants of obesity</article-title><source>Obes Rev</source><year>2007</year><volume>8</volume><fpage>93</fpage><lpage>97</lpage><pub-id pub-id-type="pmid">17316310</pub-id><pub-id pub-id-type="doi">10.1111/j.1467-789X.2007.00326.x</pub-id></citation></ref><ref id="B36"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Petersen</surname><given-names>M</given-names></name><name><surname>Taylor</surname><given-names>MA</given-names></name><name><surname>Saris</surname><given-names>WH</given-names></name><name><surname>Verdich</surname><given-names>C</given-names></name><name><surname>Toubro</surname><given-names>S</given-names></name><name><surname>Macdonald</surname><given-names>I</given-names></name><name><surname>Rossner</surname><given-names>S</given-names></name><name><surname>Stich</surname><given-names>V</given-names></name><name><surname>Guy-Grand</surname><given-names>B</given-names></name><name><surname>Langin</surname><given-names>D</given-names></name><name><surname>Martinez</surname><given-names>JA</given-names></name><name><surname>Pedersen</surname><given-names>O</given-names></name><name><surname>Holst</surname><given-names>C</given-names></name><name><surname>Sorensen</surname><given-names>TI</given-names></name><name><surname>Astrup</surname><given-names>A</given-names></name></person-group><article-title>Randomized, multi-center trial of two hypo-energetic diets in obese subjects: high-versus low-fat content</article-title><source>International journal of obesity (2005)</source><year>2006</year><volume>30</volume><fpage>552</fpage><lpage>560</lpage><pub-id pub-id-type="pmid">16331300</pub-id><pub-id pub-id-type="doi">10.1038/sj.ijo.0803186</pub-id></citation></ref><ref id="B37"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nordmann</surname><given-names>AJ</given-names></name><name><surname>Nordmann</surname><given-names>A</given-names></name><name><surname>Briel</surname><given-names>M</given-names></name><name><surname>Keller</surname><given-names>U</given-names></name><name><surname>Yancy</surname><given-names>WS</given-names><suffix>Jr</suffix></name><name><surname>Brehm</surname><given-names>BJ</given-names></name><name><surname>Bucher</surname><given-names>HC</given-names></name></person-group><article-title>Effects of low-carbohydrate vs low-fat diets on weight loss and cardiovascular risk factors: a meta-analysis of randomized controlled trials</article-title><source>Arch Intern Med</source><year>2006</year><volume>166</volume><fpage>285</fpage><lpage>293</lpage><pub-id pub-id-type="pmid">16476868</pub-id><pub-id pub-id-type="doi">10.1001/archinte.166.3.285</pub-id></citation></ref><ref id="B38"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dansinger</surname><given-names>ML</given-names></name><name><surname>Gleason</surname><given-names>JA</given-names></name><name><surname>Griffith</surname><given-names>JL</given-names></name><name><surname>Selker</surname><given-names>HP</given-names></name><name><surname>Schaefer</surname><given-names>EJ</given-names></name></person-group><article-title>Comparison of the Atkins, Ornish, Weight Watchers, and Zone diets for weight loss and heart disease risk reduction: a randomized trial</article-title><source>Jama</source><year>2005</year><volume>293</volume><fpage>43</fpage><lpage>53</lpage><pub-id pub-id-type="pmid">15632335</pub-id><pub-id pub-id-type="doi">10.1001/jama.293.1.43</pub-id></citation></ref><ref id="B39"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Astrup</surname><given-names>A</given-names></name><name><surname>Meinert Larsen</surname><given-names>T</given-names></name><name><surname>Harper</surname><given-names>A</given-names></name></person-group><article-title>Atkins and other low-carbohydrate diets: hoax or an effective tool for weight loss?</article-title><source>Lancet</source><year>2004</year><volume>364</volume><fpage>897</fpage><lpage>899</lpage><pub-id pub-id-type="pmid">15351198</pub-id><pub-id pub-id-type="doi">10.1016/S0140-6736(04)16986-9</pub-id></citation></ref><ref id="B40"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pirozzo</surname><given-names>S</given-names></name><name><surname>Summerbell</surname><given-names>C</given-names></name><name><surname>Cameron</surname><given-names>C</given-names></name><name><surname>Glasziou</surname><given-names>P</given-names></name></person-group><article-title>Should we recommend low-fat diets for obesity?</article-title><source>Obes Rev</source><year>2003</year><volume>4</volume><fpage>83</fpage><lpage>90</lpage><pub-id pub-id-type="pmid">12760443</pub-id><pub-id pub-id-type="doi">10.1046/j.1467-789X.2003.00099.x</pub-id></citation></ref><ref id="B41"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Thomas</surname><given-names>DE</given-names></name><name><surname>Elliott</surname><given-names>EJ</given-names></name><name><surname>Baur</surname><given-names>L</given-names></name></person-group><article-title>Low glycaemic index or low glycaemic load diets for overweight and obesity</article-title><source>Cochrane Database Syst Rev</source><year>2007</year><fpage>CD005105</fpage><pub-id pub-id-type="pmid">17636786</pub-id></citation></ref><ref id="B42"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dyson</surname><given-names>PA</given-names></name></person-group><article-title>A review of low and reduced carbohydrate diets and weight loss in type 2 diabetes</article-title><source>J Hum Nutr Diet</source><year>2008</year><volume>21</volume><fpage>530</fpage><lpage>538</lpage><pub-id pub-id-type="pmid">18759958</pub-id><pub-id pub-id-type="doi">10.1111/j.1365-277X.2008.00896.x</pub-id></citation></ref><ref id="B43"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pittas</surname><given-names>AG</given-names></name><name><surname>Roberts</surname><given-names>SB</given-names></name><name><surname>Das</surname><given-names>SK</given-names></name><name><surname>Gilhooly</surname><given-names>CH</given-names></name><name><surname>Saltzman</surname><given-names>E</given-names></name><name><surname>Golden</surname><given-names>J</given-names></name><name><surname>Stark</surname><given-names>PC</given-names></name><name><surname>Greenberg</surname><given-names>AS</given-names></name></person-group><article-title>The effects of the dietary glycemic load on type 2 diabetes risk factors during weight loss</article-title><source>Obesity (Silver Spring, Md)</source><year>2006</year><volume>14</volume><fpage>2200</fpage><lpage>2209</lpage><pub-id pub-id-type="pmid">17189547</pub-id><pub-id pub-id-type="doi">10.1038/oby.2006.258</pub-id></citation></ref><ref id="B44"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Noakes</surname><given-names>M</given-names></name><name><surname>Foster</surname><given-names>PR</given-names></name><name><surname>Keogh</surname><given-names>JB</given-names></name><name><surname>James</surname><given-names>AP</given-names></name><name><surname>Mamo</surname><given-names>JC</given-names></name><name><surname>Clifton</surname><given-names>PM</given-names></name></person-group><article-title>Comparison of isocaloric very low carbohydrate/high saturated fat and high carbohydrate/low saturated fat diets on body composition and cardiovascular risk</article-title><source>Nutr Metab (Lond)</source><year>2006</year><volume>3</volume><fpage>7</fpage><pub-id pub-id-type="pmid">16403234</pub-id><pub-id pub-id-type="doi">10.1186/1743-7075-3-7</pub-id></citation></ref><ref id="B45"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nestel</surname><given-names>P</given-names></name><name><surname>Cehun</surname><given-names>M</given-names></name><name><surname>Chronopoulos</surname><given-names>A</given-names></name></person-group><article-title>Effects of long-term consumption and single meals of chickpeas on plasma glucose, insulin, and triacylglycerol concentrations</article-title><source>Am J Clin Nutr</source><year>2004</year><volume>79</volume><fpage>390</fpage><lpage>395</lpage><pub-id pub-id-type="pmid">14985212</pub-id></citation></ref><ref id="B46"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Vidon</surname><given-names>C</given-names></name><name><surname>Boucher</surname><given-names>P</given-names></name><name><surname>Cachefo</surname><given-names>A</given-names></name><name><surname>Peroni</surname><given-names>O</given-names></name><name><surname>Diraison</surname><given-names>F</given-names></name><name><surname>Beylot</surname><given-names>M</given-names></name></person-group><article-title>Effects of isoenergetic high-carbohydrate compared with high-fat diets on human cholesterol synthesis and expression of key regulatory genes of cholesterol metabolism</article-title><source>Am J Clin Nutr</source><year>2001</year><volume>73</volume><fpage>878</fpage><lpage>884</lpage><pub-id pub-id-type="pmid">11333840</pub-id></citation></ref><ref id="B47"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Atkinson</surname><given-names>FS</given-names></name><name><surname>Foster-Powell</surname><given-names>K</given-names></name><name><surname>Brand-Miller</surname><given-names>JC</given-names></name></person-group><article-title>International tables of glycemic index and glycemic load values: 2008</article-title><source>Diabetes Care</source><year>2008</year><volume>31</volume><fpage>2281</fpage><lpage>2283</lpage><pub-id pub-id-type="pmid">18835944</pub-id><pub-id pub-id-type="doi">10.2337/dc08-1239</pub-id></citation></ref><ref id="B48"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Vasankari</surname><given-names>TJ</given-names></name><name><surname>Vasankari</surname><given-names>TM</given-names></name></person-group><article-title>Effect of dietary fructose on lipid metabolism, body weight and glucose tolerance in humans</article-title><source>Scandinavian Journal of Food &#x00026; Nutrition</source><year>2006</year><volume>50</volume><fpage>55</fpage><lpage>63</lpage><pub-id pub-id-type="doi">10.1080/17482970600783356</pub-id></citation></ref><ref id="B49"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Livesey</surname><given-names>G</given-names></name><name><surname>Taylor</surname><given-names>R</given-names></name></person-group><article-title>Fructose consumption and consequences for glycation, plasma triacylglycerol, and body weight: meta-analyses and meta-regression models of intervention studies</article-title><source>Am J Clin Nutr</source><year>2008</year><volume>88</volume><fpage>1419</fpage><lpage>1437</lpage><pub-id pub-id-type="pmid">18996880</pub-id></citation></ref><ref id="B50"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ferrannini</surname><given-names>E</given-names></name><name><surname>Balkau</surname><given-names>B</given-names></name><name><surname>Coppack</surname><given-names>SW</given-names></name><name><surname>Dekker</surname><given-names>JM</given-names></name><name><surname>Mari</surname><given-names>A</given-names></name><name><surname>Nolan</surname><given-names>J</given-names></name><name><surname>Walker</surname><given-names>M</given-names></name><name><surname>Natali</surname><given-names>A</given-names></name><name><surname>Beck-Nielsen</surname><given-names>H</given-names></name></person-group><article-title>Insulin resistance, insulin response, and obesity as indicators of metabolic risk</article-title><source>J Clin Endocrinol Metab</source><year>2007</year><volume>92</volume><fpage>2885</fpage><lpage>2892</lpage><pub-id pub-id-type="pmid">17504904</pub-id><pub-id pub-id-type="doi">10.1210/jc.2007-0334</pub-id></citation></ref><ref id="B51"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Weggemans</surname><given-names>RM</given-names></name><name><surname>Zock</surname><given-names>PL</given-names></name><name><surname>Katan</surname><given-names>MB</given-names></name></person-group><article-title>Dietary cholesterol from eggs increases the ratio of total cholesterol to high-density lipoprotein cholesterol in humans: a meta-analysis</article-title><source>Am J Clin Nutr</source><year>2001</year><volume>73</volume><fpage>885</fpage><lpage>891</lpage><pub-id pub-id-type="pmid">11333841</pub-id></citation></ref><ref id="B52"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Osterdahl</surname><given-names>M</given-names></name><name><surname>Kocturk</surname><given-names>T</given-names></name><name><surname>Koochek</surname><given-names>A</given-names></name><name><surname>Wandell</surname><given-names>PE</given-names></name></person-group><article-title>Effects of a short-term intervention with a paleolithic diet in healthy volunteers</article-title><source>Eur J Clin Nutr</source><year>2007</year><pub-id pub-id-type="pmid">17522610</pub-id></citation></ref><ref id="B53"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Reynolds</surname><given-names>TM</given-names></name><name><surname>Smellie</surname><given-names>WS</given-names></name><name><surname>Twomey</surname><given-names>PJ</given-names></name></person-group><article-title>Glycated haemoglobin (HbA1c) monitoring</article-title><source>Bmj</source><year>2006</year><volume>333</volume><fpage>586</fpage><lpage>588</lpage><pub-id pub-id-type="pmid">16974013</pub-id><pub-id pub-id-type="doi">10.1136/bmj.38947.627847.AE</pub-id></citation></ref><ref id="B54"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Elbourne</surname><given-names>DR</given-names></name><name><surname>Altman</surname><given-names>DG</given-names></name><name><surname>Higgins</surname><given-names>JP</given-names></name><name><surname>Curtin</surname><given-names>F</given-names></name><name><surname>Worthington</surname><given-names>HV</given-names></name><name><surname>Vail</surname><given-names>A</given-names></name></person-group><article-title>Meta-analyses involving cross-over trials: methodological issues</article-title><source>Int J Epidemiol</source><year>2002</year><volume>31</volume><fpage>140</fpage><lpage>149</lpage><pub-id pub-id-type="pmid">11914310</pub-id><pub-id pub-id-type="doi">10.1093/ije/31.1.140</pub-id></citation></ref><ref id="B55"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bantle</surname><given-names>JP</given-names></name><name><surname>Wylie-Rosett</surname><given-names>J</given-names></name><name><surname>Albright</surname><given-names>AL</given-names></name><name><surname>Apovian</surname><given-names>CM</given-names></name><name><surname>Clark</surname><given-names>NG</given-names></name><name><surname>Franz</surname><given-names>MJ</given-names></name><name><surname>Hoogwerf</surname><given-names>BJ</given-names></name><name><surname>Lichtenstein</surname><given-names>AH</given-names></name><name><surname>Mayer-Davis</surname><given-names>E</given-names></name><name><surname>Mooradian</surname><given-names>AD</given-names></name><name><surname>Wheeler</surname><given-names>ML</given-names></name></person-group><article-title>Nutrition recommendations and interventions for diabetes: a position statement of the American Diabetes Association</article-title><source>Diabetes Care</source><year>2008</year><volume>31</volume><fpage>S61</fpage><lpage>78</lpage><pub-id pub-id-type="pmid">18165339</pub-id></citation></ref><ref id="B56"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Johnson</surname><given-names>DW</given-names></name></person-group><article-title>Dietary protein restriction as a treatment for slowing chronic kidney disease progression: the case against</article-title><source>Nephrology (Carlton, Vic)</source><year>2006</year><volume>11</volume><fpage>58</fpage><lpage>62</lpage><pub-id pub-id-type="pmid">16509934</pub-id><pub-id pub-id-type="doi">10.1111/j.1440-1797.2006.00550.x</pub-id></citation></ref><ref id="B57"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mandayam</surname><given-names>S</given-names></name><name><surname>Mitch</surname><given-names>WE</given-names></name></person-group><article-title>Dietary protein restriction benefits patients with chronic kidney disease</article-title><source>Nephrology (Carlton, Vic</source><year>2006</year><volume>11</volume><fpage>53</fpage><lpage>57</lpage><pub-id pub-id-type="pmid">16509933</pub-id><pub-id pub-id-type="doi">10.1111/j.1440-1797.2006.00528.x</pub-id></citation></ref><ref id="B58"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gannon</surname><given-names>MC</given-names></name><name><surname>Nuttall</surname><given-names>FQ</given-names></name></person-group><article-title>Control of blood glucose in type 2 diabetes without weight loss by modification of diet composition</article-title><source>Nutr Metab (Lond)</source><year>2006</year><volume>3</volume><fpage>16</fpage><pub-id pub-id-type="pmid">16556307</pub-id><pub-id pub-id-type="doi">10.1186/1743-7075-3-16</pub-id></citation></ref><ref id="B59"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hunt</surname><given-names>CD</given-names></name><name><surname>Johnson</surname><given-names>LK</given-names></name></person-group><article-title>Calcium requirements: new estimations for men and women by cross-sectional statistical analyses of calcium balance data from metabolic studies</article-title><source>Am J Clin Nutr</source><year>2007</year><volume>86</volume><fpage>1054</fpage><lpage>1063</lpage><pub-id pub-id-type="pmid">17921384</pub-id></citation></ref><ref id="B60"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Winzenberg</surname><given-names>TM</given-names></name><name><surname>Shaw</surname><given-names>K</given-names></name><name><surname>Fryer</surname><given-names>J</given-names></name><name><surname>Jones</surname><given-names>G</given-names></name></person-group><article-title>Calcium supplementation for improving bone mineral density in children</article-title><source>Cochrane Database Syst Rev</source><year>2006</year><fpage>CD005119</fpage><pub-id pub-id-type="pmid">16625624</pub-id></citation></ref><ref id="B61"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tang</surname><given-names>BM</given-names></name><name><surname>Eslick</surname><given-names>GD</given-names></name><name><surname>Nowson</surname><given-names>C</given-names></name><name><surname>Smith</surname><given-names>C</given-names></name><name><surname>Bensoussan</surname><given-names>A</given-names></name></person-group><article-title>Use of calcium or calcium in combination with vitamin D supplementation to prevent fractures and bone loss in people aged 50 years and older: a meta-analysis</article-title><source>Lancet</source><year>2007</year><volume>370</volume><fpage>657</fpage><lpage>666</lpage><pub-id pub-id-type="pmid">17720017</pub-id><pub-id pub-id-type="doi">10.1016/S0140-6736(07)61342-7</pub-id></citation></ref><ref id="B62"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nordin</surname><given-names>BE</given-names></name><name><surname>JM</surname><given-names>WI</given-names></name><name><surname>Clifton</surname><given-names>PM</given-names></name><name><surname>McArthur</surname><given-names>R</given-names></name><name><surname>Scopacasa</surname><given-names>F</given-names></name><name><surname>Need</surname><given-names>AG</given-names></name><name><surname>Morris</surname><given-names>HA</given-names></name><name><surname>O'Loughlin</surname><given-names>PD</given-names></name><name><surname>Horowitz</surname><given-names>M</given-names></name></person-group><article-title>A longitudinal study of bone-related biochemical changes at the menopause</article-title><source>Clin Endocrinol (Oxf)</source><year>2004</year><volume>61</volume><fpage>123</fpage><lpage>130</lpage><pub-id pub-id-type="pmid">15212654</pub-id><pub-id pub-id-type="doi">10.1111/j.1365-2265.2004.02066.x</pub-id></citation></ref><ref id="B63"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lindeberg</surname><given-names>S</given-names></name><name><surname>Cordain</surname><given-names>L</given-names></name><name><surname>Eaton</surname><given-names>B</given-names></name></person-group><article-title>Biological and Clinical Potential of a Palaeolithic Diet</article-title><source>Journal of Nutritional &#x00026; Environmental Medicine</source><year>2003</year><volume>13</volume><fpage>149</fpage><lpage>160</lpage><pub-id pub-id-type="doi">10.1080/13590840310001619397</pub-id></citation></ref></ref-list></back></article>


